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Abstract 
 Spinal Muscular Atrophy (SMA) is a neurodegenerative disorder that represents the 
second most common cause of hereditary infant death. It is caused by the reduced 
expression of the ubiquitous protein SMN (Survival of Motor Neuron), which is known to have 
a central function in the assembly of ribonucleoprotein complexes involved in pre-mRNA 
splicing. More recently, this protein has been reported to be involved in trafficking of mRNA 
molecules along neuron axons. Although the SMA causing gene has been identified for over 
a decade, the exact mechanisms that lead to the specific death of motor neurons remain 
unclear. A long-standing hypothesis suggests that the disease emerges from motor-neuron 
specific changes in pre-mRNA splicing that affect key genes required for the survival of these 
cells. A possible approach to identify these genes is whole-transcriptome profiling. Nowadays, 
one of the most powerful tools for transcriptome profiling is next generation RNA sequencing 
(RNA-Seq), which can provide data with minimal biological variation between replicates, 
resulting in a precise comparison of different phenotypes. However this is not a bias-free 
technique and library preparation and sequencing problems can introduce several artifacts 
which need to be addressed. 
 Here we present an RNA-Seq study of disease models based on D. melanogaster 
and H. sapiens iPSC cultures developed to help unravel the pathways related to SMN down-
regulation and SMA by identifying changes in gene expression and transcript isoform 
expression. 
 During the development of the analysis pipeline for Drosophila, several difficulties 
were encountered, emerging from the inherent complexity of the process of preparing tissue 
specific RNA samples requiring dissection and pooling of multiple larvae brains, and the 
presence of an shRNA expression vector. This resulted in intra-treatment variance that 
needed to be addressed and stabilized. Furthermore, we found that some widely used 
algorithms for discovery of novel transcript isoforms can perform poorly on Drosophila, 
requiring the selection of alternative approaches. Similarly, the human analysis pipeline 
showed a high amount of variance due to the limited number of individuals used to create 
iPSC libraries, introducing bias in the analysis. 
 Finally, we showed via comparison of differentially expressed ortholog genes that 
changes caused by SMN down-regulation affect several conserved genes across species, 
making Drosophila a favourable approach for modelling SMA. 
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Resumo 
 A Atrofia Muscular Espinhal (SMA) é uma doença neuro-degenerativa que representa 
a segunda causa mais comum de morte infantil hereditária. É causada pela expressão 
reduzida da proteína ubíqua SMN (Survival of Motor neuron), que tem uma função central na 
assemblagem de complexos ribonucleoproteicos envolvidos no splicing do pre-mRNA. 
Recentemente, esta proteína também foi reportada como estando envolvida no tráfego de 
moléculas de mRNA ao longo dos axónios. Apesar do gene causador da SMA estar 
identificado há mais de uma década, os mecanismos que levam à morte dos neurónios 
motores continuam por descobrir. Uma das hipóteses sugere que a doença emerge devido a 
alterações de eventos de splicing no pre-mRNA em neurónios motores, afectando genes 
chave necessários para a sobrevivência destas células. 
 Uma abordagem possível para identificar estes genes é o estudo do perfil do 
transcriptoma, que permite identificar como alterações de expressão génica e padrões de 
splicing podem levar à activação de vias moleculares relacionadas com a doença. Hoje em 
dia, uma das ferramentas mais poderosas para estudar o transcriptoma é a sequenciação 
de RNA usando métodos de “Next Generation Sequencing”, mais conhecida por RNA-seq, 
que produz dados com o mínimo de variação biologica entre replicados, resultando em 
comparações precisas entre fenótipos. Esta técnica produz vários milhões de pequenas 
sequências de nucleótidos chamadas reads que, quando alinhadas a um genoma de 
referência, permitem quantificar os níveis de expressão do transcriptoma, servindo como a 
base de comparação entre diferentes condições. Porém, esta técnica não é livre de 
problemas de enviesamento e a preparação das bibliotecas e erros durante a sequenciação 
podem introduzir vários artefactos que necessitam de ser tratados. 
  Nesta tese apresentamos um estudo de RNA-Seq de modelos de doença de D. 
melanogaster e culturas de iPSC de H. sapiens desenvolvidas com o objectivo de 
caracterizar as vias biológicas relacionadas com a sub-expressão do SMN e as causas da 
SMA através da identificação de alterações na expressão génica e isoformas dos transcritos.  
 D. melanogaster é um modelo de doença que apresenta um grande número de 
genes conservados quando comparado a humanos. Também tem um sistema nervoso 
complexo, essencial para um estudo eficaz de doenças neurodegenerativas a um nível 
molecular. Devido a estas características, modelos de doença humana podem ser 
facilmente gerados em drosófila através do uso de vectores de expressão de “small hairpin 
RNA” (shRNA) para alterar a expressão do gene causador da doença homologo num tecido 
especifico ou em todo o organismo.  
 Para estudar os efeitos da sub-expressão de SMN em D. melanogaster foram 
produzidas bibliotecas de RNA-seq do sistema nervoso central de moscas com três 
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fenótipos diferentes: um controlo, um modelo baseado em shRNA que provoca um knock-
down médio da expressão de SMN em neurónios e um modelo severo de SMA. Durante a 
análise, encontrámos vários problemas que emergiram da complexidade inerente do 
processo de preparar amostras de RNA de um tecido especifico, que requerem a dissecção 
e pooling de múltiplos cérebros de larva e da presença de um vector de expressão de 
shRNA. Isto resultou em variância entre replicados que precisaram de ser tratados e 
estabilizados. De modo a identificar se as bibliotecas estariam contaminadas por tecido não-
neuronal, criámos um método baseado comparação dos níveis normalizados de expressão 
de genes com expressão específica em tecidos neuronais e expressão específica em 
tecidos não neuronais. Este método conseguiu identificar um padrão específico de 
expressão génica neuronal, dando-nos uma ferramenta para remover bibliotecas com um 
elevado nível de contaminação de tecido não neuronal.  
 Uma nova ronda de sequenciação mostrou reduzidos níveis de contaminação por 
tecido não neuronal porém, ao fazer uma análise de expressão diferencial entre os níveis de 
expressão dos genes do controlo vs SMA médio, SMN não foi encontrado como 
diferencialmente expresso. Concluímos que tal estaria associado ao facto do sistema 
nervoso central ser um tecido complexo e algumas das suas componentes, como as células 
da glia, não são afectadas pelo shRNA devido a não possuírem elav, necessário para a 
expressão do shRNA. Isto levou-nos a produzir uma terceira ronda de sequenciação, 
contendo o modelo severo de SMA, onde os niveis de expressão de SMN estão reduzidos 
em todos os tecidos. Nesta ronda encontrámos alterações no conteúdo de GC que foram 
demonstradas como estando relacionadas com duplicações de reads feitas pelas rondas de 
PCR antes de se efectuar a sequenciação. Neste modelo, a análise dos dados encontrou 
SMN como diferencialmente expresso bem como, ao efectuar uma “gene set enrichment 
analysis” (GSEA), vários processos biológicos enriquecidos relacionados com SMA e a sub-
expressão de SMN. Uma análise de expressão diferencial de isoformas revelou várias 
alterações atribuídas à falta de expressão de SMN, previamente observadas em outros 
estudos. Por último também observámos que alguns dos algoritmos muito usados para a 
descoberta de novas isoformas de transcritos têm uma performance pobre em drosófila, 
requerendo a utilização de abordagens alternativas.  
  O modelo usado nesta tese para o estudo de SMA em humanos é baseado em iPSC 
(induced Pluripotent Stem Cells). São culturas de células estaminais estáveis desenvolvidas 
a partir de células somáticas adultas através da expressão de quatro genes (Oct4, Sox2, 
Klf4 e c-myc) através de vectores virais, plasmídeos ou mRNA sintetizado codificando estes 
factores de transcrição. Estas culturas podem ser induzidas a diferenciar-se em vários tipos 
de células, tornando-as numa ferramenta extremamente poderosa no estudo de doenças 
genéticas humanas. Vários estudos usaram com sucesso esta abordagem para o estudo de 
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doenças neurodegenerativas como Parkinson e esclerose lateral amiotrófica. 
 Para estudar os efeitos da SMA nos humanos, foram produzidas bibliotecas de RNA-
seq de neurónios motores diferenciados de culturas de iPSC criadas a partir de fibroblastos 
de um individuo normal (controlo), o mesmo individuo normal com um shRNA que diminui a 
expressão de SMN e um paciente de SMA. A análise dos dados de RNA-seq, de um modo 
semelhante a D. melanogaster, mostrou grandes valores de variância entre condições 
devido ao número limitado de indivíduos usados para criar as bibliotecas de iPSC, 
enviesando a análise. Esta análise levou à conclusão de que o modelo de shRNA não 
diminui os niveis como esperado, não tendo sido encontrado o gene SMN1 como 
diferencialmente expresso quando comparado com o controlo bem como a análise entre 
este modelo e o paciente de SMA mostra resultados similares à análise entre o controlo e o 
paciente. A análise entre o controlo e o paciente revelaram uma grande variação biológica 
relacionada com erros de amostragem, tendo sido encontrado cerca de um terço do genoma 
humano como diferencialmente expresso. Apesar disso, foi possível encontrar o sinal de 
uma resposta de expressão génica à falta de expressão de SMN via comparação com 
estudos de SMA prévios, bem como alterações de expressão de isoformas relacionadas 
com regulação de expressão snRNPs. 
Por último, apesar dos vários desafios encontrados no processamento dos dados do 
modelo de drosófila e o modelo humano, mostrámos através da comparação de genes 
ortologos diferencialmente expressos que as alterações causadas pela sub-expressão do 
SMN afectam vários genes conservados entre estas duas espécies, mostrando que o 
modelo de Drosophila é uma boa abordagem para modelar a SMA. Também propomos 
modificações a fazer em futuros estudos usando estes modelos de modo a diminuir os erros 
de preparação das bibliotecas e sequenciação, melhorando a subsequente análise dos 
dados. 
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1 – Introduction & Objectives 
 
1.1 – Transcriptome profiling 
 Transcriptome profiling has become a major focus in biological research, showing 
how changes in gene expression and splicing patterns can lead to the activation of molecular 
pathways related to disease. Indeed, it has shed some light into the processes involved in 
the cause of neurodegenerative diseases, such as Alzheimer disease, Parkinson disease 
and amyotrophic lateral sclerosis (ALS)1,2. 
 RNA-Sequencing, or RNA-Seq3, is currently the most widely used technology to 
sequence the transcriptome. It is based on the high-throughput sequencing (also known as 
deep sequencing, next generation sequencing or NGS) of a cDNA library generated from 
steady-state RNA, producing millions of short nucleotide sequences (30-400 nucleotides in 
size) also known as reads. These reads, when mapped to a reference genome, can be used 
to quantify transcript abundances and serve as the basis for comparison between different 
phenotypes, providing information about gene expression, sequence variation in the 
transcriptome, allele specific expression levels, and exon usage, as well as allowing for the 
identification of novel splice junctions and promoters. Also, since RNA-Seq is not limited to 
the detection of transcripts corresponding to a previously known genomic sequence, it allows 
the assembly of transcriptomes of species for which a reference genome is not yet available. 
However, like all sequencing technologies, it presents a series of challenges and 
disadvantages. Because the preparation of RNA-seq libraries relies on reverse transcription 
and PCR amplification before sequencing, several types of biases have been reported as a 
consequence, including random hexamer priming bias4, GC content bias5 and depletion of 3’ 
and 5’ ends of the transcripts, which impacts read nucleotide content and read annotation 
and bias the quantification of gene expression6. 
 Creating an RNA-Seq library follows a protocol with several steps (Figure 1), the first 
one being the enrichment of mature mRNAs (which have a 3’ poly-adenylated tail, or poly-A) 
from the total extracted RNA or the depletion of ribosomal RNA (rRNA). The mature RNA is 
then randomly fragmented by hydrolysis or nebulization and reverse-transcribed into a cDNA 
via random hexamer or oligo-dT priming. Alternatively, fragmentation can be done after the 
creation of the cDNA library. RNA fragmentation results in an even read coverage over the 
transcript body with a decrease in coverage towards the transcript ends, whereas cDNA 
fragmentation results in lower read coverage over the transcript body with an increase of 
read coverage on the 3’ and 5’ ends. The cDNA library is then size selected for fragments 
suitable for sequencing by one of the various high-throughput sequencing technologies 
available (e.g: Illumina’s Genome Analyser/HiSeq, Applied Biosystems’ SOLiD, Roche’s 454 
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– reviewed in 7), which generates reads from one (single-end reads) or both (paired-end 
reads) ends of each of the selected fragments, producing up to hundreds of millions of reads.  
 
Figure 1 – A typical RNA-Seq experiment. Image and text adapted from Wang et al.
3
. “Long RNAs are 
converted into a library of cDNA fragments through either RNA fragmentation or DNA fragmentation. Sequencing 
adaptors (blue) are subsequently added to each cDNA fragment and a short sequence is obtained from each 
cDNA using high-throughput sequencing technology. The resulting sequence reads are aligned with the reference 
genome or transcriptome, and classified as three types: exonic reads, junction reads and poly(A) end-reads. 
These three types are used to generate a base-resolution expression profile for each gene, as illustrated at the 
bottom.”  
 
1.2 – A Bioinformatical approach to RNA-Seq data 
 Depending on the scientific question of interest, the analysis of RNA-seq data will 
need different and sometimes very complex approaches, some of which tend to be very 
computationally heavy, such as aligning millions of reads to a reference genome or applying 
statistical models to test for differential expression of thousands of genes and respective 
exons, in order to answer questions such as which genes are being differentially expressed, 
or which isoforms are being enriched. This can be solved by using a bioinformatics approach, 
based on specialized algorithms for finding, matching and counting patterns in files with large 
volumes of data as fast and accurately as possible. 
 An RNA-seq data analysis requires several key steps: quality filtering of raw reads, 
mapping the reads to a reference genome, removing duplicate reads, quantifying genetic 
features, and finally comparing them between different experimental treatments (Figure 2). 
As mentioned before, RNA-seq data is biased by several errors introduced during either 
library preparation or due to the sequencing technique4,5,6,8 which need to be filtered. Starting 
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out with the raw reads produced by one of the various existing NGS technologies, the first 
step is to filter out uncalled nucleotides, reads with a low Quality Score (QS), and reads with 
long homopolymers, which can bias the quantification of gene expression. Unidentified or 
uncalled bases are seen in reads as nucleotides tagged as N, identifying a position where it 
was not possible to accurately determine which nucleotide is being featured. Quality scores, 
or Phred scores9, measure the probability of a base call being correct and are defined by the 
equation              , where e is the estimated probability of the base call being 
wrong, meaning the higher the QS, the more accurate the nucleotide identification is. For 
example, if during the filtering process the QS is locked to values between 30 and 40, the 
probability of each base call being correct is at least 99.9% (QS=30) and at most 99.99% 
(QS=40). A higher or lower degree of stringency may be applied to reads based on the 
quality score, depending on the biological question. Lastly, homopolymers are a long 
repetition of the same nucleotide, usually covering 50% or more of the total read, which not 
only create noise during the base calling step, but are also ambiguous when aligning to a 
reference genome due their lack of a distinctive pattern, despite some of them being present 
in the actual transcriptome (ie: not caused by sequencing errors or library preparation errors). 
 
 
Figure 2 – A typical analysis pipeline for NGS data.  
 The second step consists of taking the filtered reads and determining their genomic 
coordinates by mapping them to a reference genome, using next generation aligners. There 
are two main types of next generation aligners: one uses algorithms based on hash tables 
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(e.g. BLAST, SOAP, MAQ) and the other uses algorithms based on suffix tries (e.g. Bowtie, 
BWA, SOAP2). Depending on the experimental design and/or biological question, these two 
algorithms have several different implementations to better suit the intended approach 
(reviewed in Li, 201010). Suffix tries algorithms based on the Burrows-Wheeler transform 
(BWT) for suffix tries are the most used algorithms for RNA-seq data mapping. In 
comparison with traditional algorithms11 (Figure 3a), BWT based aligners use a different data 
structure to store the seeds, called tries, which store all the suffixes of a sequence and 
compress them using an FM-index, a structure based on the BWT (Figure 3b). This results in 
multiple identical sequences that need to be aligned only once, increasing the alignment 
speed. 
 
Figure 3 – Comparison between two different approaches for aligning short sequencing reads to a 
genome. Image taken from from Trapnell & Salzberg
12
. a) Spaced seed index approach b) Burrows-Wheeler 
Transform based approach. 
 Overall, software based on spaced seed indexing tends to be more sensitive but 
needs a large amount of memory and is less time efficient (30 fold slower)13. As an example, 
it takes 50GB+ of RAM to store a hash table of a human genome in memory, whereas 
software that uses algorithms based on the BWT can fit the same genome in under 2GB of 
memory. Having access to a server or computer grid capable of handling information on the 
scale needed by spaced seed software to store hash tables is restricted to most researchers 
and because of this, BWT based aligners are the preferred approach for a small server such 
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as the one being used in the analysis featured on this thesis. A well known example of this 
type of software is the Burrows Wheeler Aligner14 (BWA), a widely used aligner which 
provides a cost-effective alignment of long reads (up to 1 Megabase) and allows for gapped 
alignment and nucleotide mismatches, but not reads that span splice junctions (Figure 4). 
 
Figure 4 – Differences between aligning reads to the genome and the transcriptome. Represented in green 
are reads that can only be recognized by aligners that allow for detection of splice junctions. The reads’ sequence 
contains part of two exons that have an intron separating them on the genome, which needs to be taken into 
account when aligning against the genome. The blue lines represent reads whose alignment spans only part of 
one exon and therefore aren’t affected by intronic sequences when aligning to the genome. 
 Other software has been developed to address the limitations of the previous aligners, 
expanding their capabilities. One such example is TopHat15, which takes RNA-Seq reads 
and compares them to the supplied reference genome in order to identify exon-exon splice 
junctions, based on the mapping provided by Bowtie13, another BWT short read aligner which 
does not recognize reads overlapping splice junctions. With TopHat, reads are initially 
mapped by Bowtie to a reference genome, creating 2 files: one with mapped reads and 
another with unmapped reads. The unmapped reads are collected by TopHat and used to 
create a seed table index which allows the software to align them by taking into consideration 
that they can span splice junctions. This also allows for novel transcript discovery by aligning 
the raw data against the genome without giving any reference about intron/exon locations.  
 The third step comes in as an addition to the filtering step, as some sources of bias 
can only be detected after the reads have been mapped to the genome. As mentioned 
previously, during the RNA-Seq protocol, the RNA/cDNA is randomly fragmented, greatly 
lowering the probability of one of the generated fragments being exactly the same as another. 
If the same exact fragment is observed, it most probably indicates a duplication error, also 
known as PCR duplication, which results from overextending the number of PCR cycles 
needed during the amplification step, meaning the amplification process went beyond the 
point of saturation, resulting in duplicated fragments, or due to a high variance in fragment 
size, which results in an over-representation of smaller, more quickly amplified fragments. To 
detect them, specialized software such as SAMTools16 and Picard17 contain a feature that 
searches and filters out identical reads and/or reads that align in the exact same 
chromosomal coordinates. 
 Mapping the reads to the genome provides little information about the transcript 
abundance, and in order to extract information from the mapped reads, scripts have been 
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developed to count the number of reads mapping to the features contained in a given 
reference. This means you can count all reads which, for example, align against every known 
gene on a specific genome, compare their expression levels between two RNA-Seq libraries 
with different conditions (e.g.: control library vs disease library) and perform a differential 
expression analysis to better understand what qualifies as a condition-specific 
gene/isoform/other feature expression or simple biological variation. This step uses one of 
the numerous differential expression analysis (DEA) packages available (edgeR18, DESeq19, 
DEXSeq20, Cuffdiff21, SAMSeq22, among others) to find which genes, isoforms or other 
features are being differentially expressed between conditions. Choosing the software will 
depend on the amount and type of data you have (reviewed in Soneson & Delorenzi23). 
Typically, these packages also contain some sort of data normalization process to reduce 
bias between different sized libraries and different gene lengths. 
 Finally, further data analysis can be performed with a gene set enrichment analysis 
(GSEA), which determines in which biological processes, molecular functions and pathways 
the DE genes/isoforms/etc are involved. With this information one can narrow down which 
pathways are being affected/triggered by the disease/treatment and derive some biological 
insight from the analysis. 
 
1.3 – Disease models 
 Disease models play an important role in assessing which systems and pathways are 
affected by a certain disease. A commonly used model is Drosophila melanogaster, an 
organism that has been shown to have a great number of highly conserved genes when 
compared to humans24. It also has a complex nervous system, an essential characteristic for 
an effective study of neurodegenerative disorders at a molecular level25,26. Due to these 
features, human disease models can be easily generated in Drosophila through the use of 
small hairpin RNA (shRNA) expression vectors to target the Drosophila homologue of the 
disease causing gene in a tissue specific or organism wide manner, making it a very reliable 
and flexible approach to modelling disease. It can be used to create stable transgenic 
Drosophila mutant lines that can be used to address the impact of loss of function mutations 
on, for example, the central nervous system (CNS).  
 
1.4 – Spinal Muscular Atrophy 
 Spinal Muscular Atrophy (SMA) is the second most common autosomal recessive 
disorder in humans, which presents itself by causing a degeneration of motor neurons33, 
leading to an atrophy of the muscles and subsequently, respiratory insufficiency, paralysis 
and death. Its cause is known to be associated to the reduction of expression of the SMN 
(Survival of Motor Neuron) protein, due to a loss of function by the Survival of Motor Neuron 
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1 gene – SMN1 – via deletions or, more rarely, missense mutations. This protein is known to 
have an important function in the assembling process of spliceosomal small nuclear 
ribonucleoproteins (snRNPs), but a link between its function and the degeneration of motor 
neurons has not yet been successfully established34. Nevertheless, it has been hypothesized 
that changes in pre-mRNA splicing mechanisms induced by a reduction of SMN expression 
affect other unknown genes, necessary for the survival of neuronal cells and neuromuscular 
junctions35.  
 In humans, there are two SMN producing genes – SMN1 and SMN2 – which differ by 
a single nucleotide substitution in exon 7 (position 840, C to T), and are located in 
chromosome 5 in the telomeric and centromeric region, respectively. Even though this 
substitution is translationally silent, it prompts an alternative splicing event on SMN2, which 
skips exon 7 and causes about 85% of the proteins produced by SMN2's transcripts to be 
truncated, making it unable to compensate for the lack of SMN production in the event of a 
loss of function by SMN1. This implies that while the disease manifests itself due to SMN1 
loss of function, its severity is dependent on the number of existing SMN2 gene copies, 
which determine how much functional, full-length SMN protein is being expressed. 
 On the other hand, D. melanogaster only has one SMN gene copy (Smn - chr 3L 
16573498-16574647) and knocking down its expression results in lethality at the larval stage. 
Therefore, in order to mimic a human SMN1 loss of function, RNA interference (RNAi) is 
used to target the fly’s Smn expression and reduce it to mimic SMN2 levels of expression. 
Previously existing studies on the cause of SMA have been based in null mutant models36,37 
where the SMN gene is disabled across all tissues, incurring in larvae lethality and thus not 
emulating the same conditions as a mild human SMA phenotype. By using a tissue specific 
driver to target only SMN production on the CNS, one can create specimens that more 
accurately profile the changes caused by this disease38. 
 
1.5 – Objectives 
 The work presented in this thesis aims to investigate how the genetic program of 
motor neurons is affected by the decrease of SMN expression, using RNA-Seq libraries from 
two disease models. The first one is an RNAi D. Melanogaster model that targets and lowers 
SMN expression in the central nervous system (CNS). The second model is based on iPS 
cell cultures differentiated from human SMA patients and healthy individuals. Furthermore it 
aims to assess the similarity between D. melanogaster and H. sapiens models, which should 
contribute with some insights regarding the usefulness of D. melanogaster’s models for the 
study of SMA disease.  
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2 – Materials & Methods 
 
SMA D. melanogaster models, tissue preparation, RNA extraction and sequencing. 
Briefly, Drosophila transgenic RNAi models were developed by Dr. D. Van Vactor’s group 
(HMS, US) using a binary system that uses the offspring obtained from a cross of two 
transgenic fly lines. The first line contained the neuron-specific elav promoter upstream of the 
yeast GAL4 transcription factor coding sequence, while the second line had an integrated 
copy of the pWIZ vector with an intron-spliced hairpin transcript that produces a double 
stranded RNA for Smn, fused to the yeast upstream activator sequence (UAS) that is bound 
by GAL4 (Fig 5). Consequently, the offspring presents a neuronal-specific down-regulation of 
SMN, where elav was used as a tissue specific GAL4 driver39. In essence, GAL4 is only 
expressed where elav is active (neuronal cells) and the RNAi is only transcribed when GAL4 
is present. A parallel cross using a fly line containing an integrated copy of the empty pWIZ 
vector was used to generate a control wild-type (WT) strain for these studies. 
 
 
 
Figure 5 – The elav-GAL4 model. a) The elav-GAL4 construct (modifed image from Dow, Julian A T
40
) b) 
Representation of the Smn gene area targeted by C24. 
 Additionally, a null allele of Smn (Df(3L)SmnX7) was used to generate a more severe 
knockdown of Smn levels, combining a 50% reduction of expression across all tissues with 
the neuronal specific Smn RNAi line (C24/X7)38. In total, four strains were used: w; 
P{w+mC=GAL4-elav.L}3 (Bloomington), w; P{UAS-PIWZ }15, w; P{UAS-SmnRNAi-C24}, and 
w; Df(3L)SmnX7, P{UAS-SmnRNAi-C24}/TM6B, Dfd-YFP to create the wild-type and mutants, 
via crosses (Figure 6). 
a) 
b) 
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Figure 6 – Drosophila lines used in this study. Details the crosses made to obtain the studied genotypes 
(WT,C24 and X7/C24) 
 The central nervous system (CNS) of approximately 200 late third instar larvae was 
dissected in order to generate one biological replicate of the corresponding genotype. 
Dissected CNS samples were quickly frozen in TriPure Isolation Reagent (Roche 
Diagnostics GmbH, Mannheim, Germany) and pooled before performing total RNA extraction 
as described in Amaral et al. 201441. In total, six biological replicates from WT flies, seven 
biological replicates from C24 flies and 4 biological replicates from X7/C24 flies were 
generated. mRNA-libraries were generated from an average 10g of total RNA and prepared 
using the TruSeq RNA Sample preparation protocol (Illumina, USA). In summary, after two 
cycles of poly-A selection, RNA was fragmented to an average length of 300 bp and then 
converted into cDNA by random priming. The cDNA was then converted into a molecular 
library in order to generate paired-end RNA-seq libraries of 100 bp using the HiSeq2000 
(Illumina, USA). 
 
RNA-seq libraries of human iPSC-derived motor neuron cultures. Human motor neuron 
samples were produced by Dr Lee Rubin’s group (Harvard Medical School) from retroviral 
generated iPSCs derived from type I SMA patient fibroblasts and control healthy fibroblasts 
as described in42. Furthermore, iPSCs derived from fibroblasts of the same healthy donor 
with an integrated shRNA vector targeting SMN1 were used in parallel to generate in vitro 
differentiated motor neurons (shSMN2). Total RNA was extracted and paired-end RNA-seq 
libraries were prepared as described. A total of 3 NS, 3 SMAiPS and 3 shSMN2 100bp RNA-
seq libraries were sequenced using the HiSeq2000 (Illumina, USA). 
 
Filtering, alignment and annotation. (See Figure 7 for the workflow) Raw data was 
analysed with FastQC to assess and visualize library's overall quality. Reads with 
homopolymers longer than 50 nt (>=50% of the read), non-called bases (tagged as N) and 
quality scores lower than 30 (QS < 30) were discarded using an in-house Perl script. The 
trimming of the first 10 nucleotides from each read (Appendix IV - Protocol 1) was made 
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using an in-house script in Python. Read alignment was made using the Burrows Wheeler 
Aligner v.0.6.1 (BWA) aln and sampe commands, allowing for only one mismatch and a 
distance of 200 nucleotides between read pairs, (Appendix IV - Protocol 2). Another aligner 
was also used TopHat9 using two modes, one with the novel junction discovery feature on 
and another with novel junction discovery off. The genome assembly used for D. 
melanogaster was the BDGP5, and for H. sapiens was the GRCh37.71. SAMTools' “rmdup” 
feature16 was used to remove potential PCR duplicates (Appendix IV - Protocol 2). Finally, 
gene counts were made with HTSeq's “count” feature in union mode43. In order to identify 
GAL4 transcripts, all reads were mapped to GAL4 gene (Gene ID 855828; accession 
NC_001148.4 - Saccharomyces cerevisiae S288c) using BWA14 with the same previously 
described alignment parameters (Appendix IV – Protocol 3). 
 
Figure 7 – Worfklow used for the analysis of the RNA-Seq libraries in both humans and flies. 
 
Differential expression analysis and pathway enrichment. Data normalization was made 
using a size factor approach and tested for differential expression analysis by using 
bioconductor’s DESeq44 package, which encodes an algorithm based on the binomial 
negative model. DESeq was also used to for the biological assessment of libraries by 
correlating gene expression and variance values between libraries. Cuffdiff21 was also used 
to test for differential expression of gene counts derived from the TopHat alignment. Out of 
the various available differential expression analysis softwares, DESeq uses one of the most 
statistically conservative methods and thus is less prone to find false positive results when 
performing differential expression tests23. Isoform DEA was made with DEXSeq20, DESeq's 
equivalent for studying isoform expression. Clustering analysis was performed using the 
heatmap function from the ggplot package (default parameters) and correlation plots were 
generated using the lattice package in R environment45. Gene set enrichment analysis was 
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performed using “GOstats”46, a bioconductor R package, in conjunction with other 
bioconductor packages, including “org.Dm.eg.db”47, ”org.Hs.eg.db”48, “KEGG.db”49, 
“GO.db”50, “biomaRt”51 and “multtest”52. 
 
Co-expression of ortholog genes between different models. Using BioMart53 and the 
HGNC54 database, a list of human/fly ortholog genes holding a HUGO ID was obtained. 
From this list, all genes that were previously identified as DE on both species were selected 
and used to generate a list of ortholog DE genes present in both species (Figure 8).  Finally, 
a gene set enrichment analysis was performed using the GOstats R package46 in order to 
understand which GO terms were being enriched by the DE ortholog genes. Note that only 
genes which were equally up-regulated or down-regulated in both species were used for the 
GSEA. 
                                         
 
Figure 8 – Pipeline for the analysis of co-expression of a) D. melanogaster and H. sapiens ortholog genes 
and b) M. musculus and H. sapiens ortholog genes 
 
GC content assessment between introns and exons. GC content for each library was 
quantified using an in-house python script which counts and separates reads according to 
the percentage of GC content. All read counts were normalized according to library size and 
the ratio between the GC content in aligned introns/genes across conditions was calculated.  
 
 
 
 
 
 
 
 
 
a) b) 
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3 – Results & Discussion 
 
3.1 – D. melanogaster model 
 To study the effects of SMN’s down-regulation on Drosophila’s CNS we analysed 
three distinct phenotypes. This analysis had the aim of uncovering which genes, exons and 
related pathways are affected by this down-regulation in this model and how it related to 
other studies using different Drosophila models, as well as its similarity with human SMA 
patients and it followed the pipeline described in methods, which includes data quality 
filtering of the generated datasets, alignment to a reference genome, differential expression 
analysis of genes and exons, and finally gene set enrichment analyses. 
 
3.1.1 – Quality assessment of mRNA-seq libraries derived from the CNS of fly larvae 
The datasets used in this study originated from three successive rounds of 
sequencing. The first sequencing batch is comprised of four biological replicates of CNS 
samples from a mild Smn knock-down mutant (C24) and three replicates of wild-type CNS 
(WT). The second batch contains three C24 and three WT replicates and the third batch has 
four biological replicates of the severe Smn knock-down mutant (X7/C24). 
 In the first batch/pilot run, we obtained an average of 100 million raw reads per library 
(Appendix I – D. melanogaster), 80% of which passed the initial quality filtering process. On 
average, 90% of the filtered reads were aligned to the genome using BWA, and ~75% of 
them were counted as part of a protein coding gene. After filtering, nearly 90% of the 
transcriptome was covered, with a sequencing depth of 500X and with an average of 11400 
protein coding genes expressed, out of a total of 13872.  In addition to the alignments made 
with BWA, we also used TopHat in this study, as it is one of the most widely used and well 
regarded softwares for alignment. Results show however, that in comparison with BWA and, 
despite TopHat having mapped an additional 5% of quality approved reads, the proportion of 
pairs that were accurately mapped was 20% less. Since TopHat has a lower coverage, this 
lead to the decision of using BWA as the preferred aligner to produce results for the 
downstream analysis.  
 We also observed that the percentage of read duplicates in C24 3 and WT 3 were 
much higher in comparison to the other replicates, indicating a problem in the library 
generation step, probably due to PCR saturation. As previously mentioned, PCR duplication 
is an issue that can lead to a skewed downstream analysis, since it introduces bias in gene 
expression by changing their expression levels due to the high number of read duplicates, 
which are being mapped as regular reads and counted as part of the gene expression levels. 
 To confirm if the libraries display the expected correlation with their assigned 
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phenotype, we performed a hierarchical clustering analysis and a correlation analysis, based 
on the whole-genome expression profiles. Results show that samples did not cluster 
according to phenotype (Figure 9), nor did the correlation values show consistency between 
libraries. For example, the WT1 dataset shows a higher correlation to the C24 libraries than 
to the WT 2 library. Given the technical complexity involved in isolating larvae CNS samples 
for RNA-seq profiling, we hypothesized that the presence of non-CNS tissue might be the 
major cause of the observed discrepancies, and that the Imaginal Discs (ID) could represent 
the largest source of contamination due to their proximity to the CNS at the studied larval 
stage. 
 
    
Figure 9 – Clustering and correlation analysis of the first sequencing batch. C24 1 to 4 represent the 
datasets generated for the mild Smn knockdown mutant, while WT 1 to 3 represent the control. a) Clustering 
between all samples from the first sequencing batch based on stabilized variance. The plot shows that the 
datasets are clearly not clustering according to phenotype; b) Correlation plot between all samples from the first 
sequencing batch, based on gene expression values normalized by DESeq (the higher the value, the higher the 
correlation is between libraries). 
 We further hypothesized that by selecting a set of key marker genes it could possible 
to identify mRNA-seq libraries that were displaying levels of gene expression closest to the 
expected for CNS derived samples. Using FlyBase's high-throughput expression data55, we 
selected five genes: two tissue specific genes (elav, repo) and three ubiquitous genes (Pen, 
Usp7 and the RNAi target gene, Smn). elav has a neuronal specific expression while repo is 
reported has having a CNS glial cell specific expression. Although ubiquitous, Pen has a 
higher expression in the imaginal discs than on the CNS and Usp7 is evenly expressed 
across most tissues. Additionally, the transgene driver GAL4 was also selected to be 
included in this profile. GAL4’s expression is regulated by the presence of elav and is not 
present on wild type D. melanogaster (Table 2). Smn, elav, repo, Pen and Usp7 expression 
a) b) 
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levels were obtained for all libraries by quantifying the paired-end reads aligned to the 
Drosophila genome with HTSeq and then normalized for gene length. GAL4 expression 
levels were quantified by aligning the RNA-Seq libraries to a “one-gene genome” created 
from the GAL4 gene fasta sequence and counting the uniquely aligned reads. A comparison 
of the expression levels of these six genes across all libraries from the first sequencing batch 
(Figure 10) confirmed the hypothesis that several libraries display a non-neuronal expression 
pattern (namely WT 1 and 2 and C24 1), giving a basis for excluding these from the dataset, 
as well as defining criteria for control of biological origin for further sequencing rounds. 
 
Table 1 – Gene expression levels of the benchmarking genes described in Flybase’s high-throughput 
expression database and their respective gene length for the central nervous system (CNS) and imaginal 
discs (ID). Note that GAL4 is a yeast gene introduced for the purpose of the experiment and does not have any 
kind of gene expression in a regular fly. The values represent the modENCODE’s expression level measure: very 
low expression (1-3), low (4-10), moderate (11-25), moderately high (26-50), high (51-100), very high (101-1000) 
and extremely high expression (>1000) 
Expression 
levels 
Pendulin Smn Usp7 elav repo GAL4 
CNS 111 76 71 82 25 
No 
expression 
ID 498 132 58 6 3 
No 
expression 
Gene 
Length (bp) 
3189 876 6200 10763 3408 2645 
 
 
Figure 10 – Benchmarking genes’ expression values for the first sequencing batch libraries, normalized 
for library size and gene length. WT 3 and C24 2-4 gene expression values correspond to neuronal tissue 
expression. All other samples (WT 1, WT 2, and C24 1) display almost no elav expression (neuron specific gene). 
WT 2 and C24 1 also display very high levels of SMN, expected from tissue derived from imaginal discs.  
 We also observed that GAL4 expression levels did not follow elav's expression levels 
in samples C24 3 and WT 3, the two libraries that had been previously observed as having a 
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higher amount of PCR duplicates. In fact, when performing the clustering analysis with the 
samples that passed the tissue specific analysis, these two samples did not cluster as 
expected, showing a clear separation between libraries according to the amount of 
duplicates (Figure 11). These results supported the final decision that the pilot sequencing 
round did not provide data with sufficient quality for performing a differential expression 
analysis and that therefore a new sequencing round would have to be performed.   
 
Figure 11 – Clustering analysis of the four libraries that passed the benchmarking gene assessment. 
Samples are being clustered according to the amount of PCR duplicates present on each dataset rather than by 
phenotype (~60% in C24 3 and WT 3, ~40% in C24 4 and C24 2). 
 
3.1.2 – Characterization of the transcriptome of the CNS of neuronal Smn knockdown 
Drosophila lines modelling a mild SMA phenotype 
 A second batch of data was produced containing three new replicates of CNS 
samples from wild type and C24 larvae.  In this batch, an average of 101,7 million raw reads 
were obtained per library (Appendix I – D. melanogaster), 84,5% of which passed the initial 
quality filtering process. On average, 91,4% of the filtered reads were aligned to the genome 
using BWA, and ~76,7% of them were counted as part of a protein coding gene. After 
filtering, nearly 90% of the transcriptome was covered, with a sequencing depth of 500X and 
with an average of 11824 protein coding genes expressed, out of a total of 13872. PCR 
duplication accounted for an average of 28% of the uniquely aligned reads, much less than 
the duplication rates found on the first sequencing batch. 
 The gene panel described in the previous section, used to evaluate library quality 
regarding their tissue of origin was also used to assess this sequencing batch. In this batch, 
all samples present the same kind of expression pattern previously found to be indicative of 
neuronal tissue, suggesting that these samples presented a much smaller degree of 
contamination from neighbouring tissues (Figure 12). However, the clustering analysis failed 
once more to classify these libraries according to their origin, with C24 6 and WT 5 being 
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clustered separately from the other libraries (Figure 13).  
 
 
Figure 12 – Expression values of the benchmarking genes from the second sequencing batch and the 
first sequencing batch samples that passed the test. 
 
 
Figure 13 – Clustering analysis of the second sequencing batch. As seen, C24 6 and WT 5 are not clustering 
according to phenotype. 
 Following these observations, we decided to investigate if these samples were being 
affected by a slightly higher presence of other non-neuronal tissues when compared to the 
other libraries. As before, using the public repository of RNA-seq data in Flybase, we 
quantified the gene expression levels which are exclusive to the neuronal system, as well as 
genes that display a high expression in other tissues (imaginal discs, carcass, fat body, 
salivary glands and digestive system) but have low to no expression in the neuronal system. 
Results (see Appendix II) showed that WT 5 has higher expression levels on genes present 
in the imaginal discs, digestive system, carcass and salivary glands but not on the CNS. C24 
6 on the other hand, had lower expression levels for CNS specific genes though it 
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maintained the same expression levels as the other samples on the non-CNS tissues. These 
altered levels of gene expression however, were not considered to be enough to skew the 
downstream analysis since both libraries passed the assessment for neuronal specific gene 
expression with almost the exact same expression pattern of the other replicates, suggesting 
both libraries should not be discarded. After the tissue-specific gene assessment, we 
performed a principal component analysis (PCA) with all the approved libraries from both 
sequencing batches (Figure 14). Again, results showed C24 6 and WT 5 as possible outliers, 
though a clear separation between WT and C24 can be observed. 
 
Figure 14 – Transcriptome profiling of the second sequencing batch. a) Principle Components Analysis 
(PCA) plot and b) Hierarchical clustering of the second sequencing batch libraries and the viable C24 replicates 
from the first sequencing batch. 
 Considering the apparent differences between the libraries from the second 
sequencing batch, we decided to perform two DE analysis, one using all six libraries (3x3 
analysis), and another using only the two replicates for each condition that displayed good 
results in both the clustering analysis and the tissue-specificity assessment (2x2 analysis). 
Results show a relatively small number of significantly DE genes (adj-p > 0,05) in both 
approaches: 78 genes in the 3x3 analysis, 209 in the 2x2 analysis, 61 of which are common. 
Unexpectedly, neither analysis identified the shRNA target, SMN, as differentially expressed 
showing only a slight change in gene expression levels (Table 2). 
 
Table 2 – SMN’s expression fold change between WT and C24 libraries. Using three replicates for each 
condition (3x3) and removing the two replicates that did not clustering according to phenotype (2x2).  
Approach SMN fold change (log2) 
Significant? 
(adj-p < 0,05) 
3x3 -0,13 no 
2x2 -0,19 no 
  
Two possible reasons might explain this outcome. The first one is that SMN’s expression 
levels in the C24 libraries were overestimated due to a bias caused by the assignment of 
a) b) 
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shRNA derived reads to the SMN gene. As previously explained, the shRNA knockdown of 
SMN is mediated by the expression of an antisense transcript corresponding to 
approximately half of the endogenous transcript (see Figure 5b). Therefore, we decided to 
investigate if a bias in the SMN read coverage towards the region complementary to the 
shRNA was observed. For this purpose, we used the results from the second sequencing 
batch to plot the distribution of all reads aligned to Smn across its chromosomal location in 
order to see if there was a significant difference in read distribution between the area 
targeted by the shRNA, C24, and the area that is not targeted by C24. If true, we also 
hypothesized that it would be possible to observe a difference in gene expression between 
WT and C24 in the area not targeted by the shRNA. Results indicate this is not the case 
(Figure 15a), suggesting that shRNA expression did not interfere with the target gene's 
quantification. This quantification of SMN’s read coverage revealed that it is higher in the 
transcript body and decreasing towards the ends. This is what is expected in RNA-seq 
libraries generated from RNA fragmentation, as described in the methods section (Figure 
15b). We therefore concluded that the shRNA used in this study was not biasing the 
estimation of SMN expression levels. 
 
a) 
b) 
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Figure 15 – SMN read distribution. a) Distribution of the reads aligned to the SMN gene in the second 
sequencing batch by their chromosomal location. The grey area indicates C24’s target and the black arrow 
indicates Smn’s start site; b) Taken from Wang et al.
3
 - Read distribution along a gene according to the type of 
fragmentation used in the library preparation. 
 The second possibility was based on a lack of a significant reduction of SMN 
expression in C24 libraries, probably due to the shRNA not having an impact on SMN 
expression as great as expected. To test this, we perfoemed a blind DE analysis by doing a 
DEA to random combinations of the data set: three 2x2 and three 3x3. Results show an 
average of 20 DE genes in the 3x3 analysis and an average of 14 DE genes in the 2x2 
analysis with none of them overlapping either WTxC24 gene DEAs. These results suggested 
that the DE genes found on the WTxC24 DEAs are not a result of random biological variation 
across all samples but of the SMN-dependent variation found between the two conditions 
(WT and C24). 
 Having dismissed both possibilities, we put forth a third hypothesis based on the fact 
that the central nervous system is a complex tissue comprised of several cell-types, including 
glial cells. These cells do not express elav, which is necessary to activate the expression of 
the shRNA that targets Smn and down-regulates its expression levels. Since the C24 shRNA 
model has been shown to work in studies where its expression is ubiquitous38, the presence 
of the glial cells in these libraries coupled with the tissue specific driver implemented in this 
fly model could explain why SMN levels are not being significantly affected, as the SMN 
expression stemming from the glial cells is not being targeted by the shRNA, masking the 
down-regulation caused on neuronal cells. At this point however, it was not possible for us to 
determine if the presence of glial cells had a significant impact in the expression of SMN 
without a phenotype where Smn is ubiquitously down-regulated. 
 
3.1.3 - Characterization of the CNS transcriptome of Drosophila lines with neuronal 
Smn knockdown on a heterozygous null background 
 Since the previous results lead us to the hypothesis that the effect of the shRNA on 
SMN expression levels proves to be difficult to detect in a complex tissue such as the CNS, 
the creation of new libraries derived from a more severe SMA D. melanogaster model would 
be required to further understand the effects of SMN down-regulation on the CNS 
transcriptome. To that effect, a third sequencing batch was produced, including four 
replicates of the severe SMA Drosophila model (X7/C24). This model presents a null 
mutation of the Smn gene (X7) in heterozygosity, over which the neuronal specific C24 
shRNA was introduced. 
 In this third batch we obtained an average of 100,7 million raw reads per library 
(Appendix I – D. melanogaster), 86% of which passed the initial quality filtering process. On 
average, 92,2% of the filtered reads were aligned to the genome using BWA, and 75,5% of 
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them were counted as part of a protein coding gene. After filtering, nearly 90% of the 
transcriptome was covered, with a sequencing depth of 500X and with an average of 11771 
protein coding genes expressed, out of a total of 13872. PCR duplication accounted for an 
average of 30% of the uniquely aligned reads (similar to what we found in the second 
sequencing batch) except for the fourth replicate (named X7/C24 D), which was flagged for 
having a much higher percentage of duplicates (~50% of the mapped reads flagged as 
duplicates). We believe this may have been caused by a lower cDNA input used for X7/C24 
D which lead us to remove this library from the downstream analysis, followed by an 
excessive number of PCR cycles which saturated the sample, producing an mRNA-seq 
library with low transcript complexity (see Appendix I – D. melanogaster). All the other 
samples passed the hierarchical clustering assessment and showed a clear separation 
between conditions when compared with the WT libraries from the second batch (Figure 16). 
Furthermore, the tissue specific analysis showed that all four samples displayed a gene 
expression pattern corresponding to CNS tissue (Figure 17). 
 
 
Figure 16 – Transcriptome profiling of the X7/C24 dataset (third sequencing batch). a) Hierarchical 
clustering between X7/C24 and WT (2
nd 
batch); as seen, X7/C24 D is clearly not clustering according to 
phenotype. b) PCA plot comparing the WT libraries from the second batch and the X7/C24 libraries that passed 
the quality filtering step. A clear separation between both phenotypes can be observed. 
 
a) b) 
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Figure 17 - Expression values of the benchmarking genes from the second sequencing batch and third 
sequencing batch samples, normalized for gene length and library size. All X7/C24 datasets present a 
neuronal tissue gene expression.  
 As seen below (Figure 18), we also observed unusual increase of GC content in 
mRNA-seq libraries derived from the severe SMA Drosophila model in reads containing 
between 19 and 40% GC content. Since introns have been shown to have a lower GC 
content than exons56, we hypothesized the origin of this peak could be related with an 
increased intron retention caused by Smn’s down-regulation due to its function on snRNP 
assembly. Alternatively, it could be related with a contamination by another species, such as 
bacteria, which are known to have widely varied levels of GC content57. To test this, we 
analysed the alignment percentage in the 19-40% GC content area in all three conditions 
(WT, C24 and X7/C24) using the datasets from the second and third sequencing batch, and 
we searched for reads from this interval that aligned to all known Drosophila introns in order 
to assess the ratio between introns and reads mapped to genes. 
 
 
Figure 18 – Read GC content distribution for a) WT and b) X7/C24. The blue line represents the theoretical 
distribution curve, whereas the red line represents the actual GC count content found on the libraries. 
 Focusing on the abnormal peak formed in the X7/C24 libraries, the mean read 
distribution between 19 and 40% total GC content was as follows: 95% of the reads on the 
interval were aligned to the genome in both WT and X7C24, and 68,8% of those had a gene 
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feature in the X7/C24 dataset, versus 69,8% in the WT. These results dismiss the possibility 
of contamination from other species, as the remainder 5% of non-aligned reads would not 
cover for the observed read increase.  
 To assess for retained introns, we searched within the reads with 19-40% GC 
contents for reads that overlap with known Drosophila introns. Results showed that the ratio 
between reads that featured introns and reads that featured protein coding genes was 
constant between conditions and GC content percentage (Figure 19) leading us to the 
conclusion that the extra peak in the 19-40% GC content area was not caused by an 
increase of intron retention, as no significant changes were being observed across conditions.  
 Some studies suggest the differences in GC content distribution are related to library 
preparation, especially due to PCR duplication58. Considering PCR duplication accounts for 
an average of 30% of the datasets studied here, we believe that the origin of the peak may 
be related to library preparation. As mentioned before, results also showed that this peak did 
not seem to be affecting the alignment results, suggesting the downstream analysis would 
not be impaired. 
 
Figure 19 – Intron feature/protein coding feature ratio for the second and third sequencing batch libraries 
on reads with 19-40% of GC content. 
 In order to identify differences in gene expression values in the X7/C24 libraries, we 
compared them to the WT libraries of the second sequencing batch via a DEA with DESeq. 
Results show a list of 2844 DE genes (adj-p < 0,05), including the hallmark gene Smn (log2 
fold change: -1,15) as expected. To assess which pathways were being affected by the gene 
expression changes found, we performed a GSEA for the X7/C24 DE gene list. Results show 
393 significantly enriched biological process (BP) pathways (adj-p < 0,05) with an emphasis 
on pathways related to neuronal processes, splicing, RNA processing and protein assembly 
(Table 3), all of which are results that are in agreement with the functions attributed to Smn 
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and its down-regulation, as well as SMA. 
Table 3 – Selected terms (lowest adj-p) from the GSEA (BP) for the list of genes obtained in the 
WTxX7/C24 gene DEA. All terms with a term size higher than 500 were filtered out due to being too high up in 
the ontology. 
GO ID Gene Count Term Size Terms  Ajusted p-value 
GO:0048666 232 420 neuron development 7,54E-23 
GO:0000904 235 427 cell morphogenesis involved in differentiation 5,66E-22 
GO:0007268 139 225 synaptic transmission 3,89E-19 
GO:0051960 96 146 regulation of nervous system development 6,84E-16 
GO:0007411 106 187 axon guidance 1,90E-11 
GO:0048523 191 422 negative regulation of cellular process 2,36E-09 
GO:0016071 147 300 mRNA metabolic process 3,42E-09 
GO:1901861 44 65 regulation of muscle tissue development 2,15E-08 
GO:0007417 110 215 central nervous system development 2,17E-08 
GO:0006396 171 379 RNA processing 2,16E-07 
GO:0007269 37 55 neurotransmitter secretion 2,82E-07 
GO:0045664 37 56 regulation of neuron differentiation 5,95E-07 
GO:0000375 110 227 RNA splicing, via transesterification reactions 6,20E-07 
GO:0050768 23 29 negative regulation of neurogenesis 7,76E-07 
GO:0031644 34 52 regulation of neurological system process 2,51E-06 
GO:0001558 31 46 regulation of cell growth 2,78E-06 
GO:0050804 33 51 regulation of synaptic transmission 4,73E-06 
GO:0016079 29 43 synaptic vesicle exocytosis 5,34E-06 
GO:0034329 30 45 cell junction assembly 5,39E-06 
GO:0000398 99 212 mRNA splicing, via spliceosome 1,27E-05 
 
 By separating the DE gene list between up-regulated genes and down regulated 
genes in and performing a GSEA in order to see if there were specific pathways with mainly 
negative or positive changes, we found the same previous pathways significantly enriched 
distributed between both analyses. We also observed a clear separation of types of 
pathways between up and down-regulated genes. The up-regulated genes showed an 
enrichment of pathways related with several growth differentiation-related processes, 
including the morphogenesis of brain, neurons and eye, neuron projection and muscle 
development as well as mRNA splice site selection-related genes (see Annex III – D. 
melanogaster). On the other hand, the negatively regulated genes show a down-regulation of 
ribosome biogenesis, protein synthesis, neuronal development, splicing and DNA repair. 
Upon further observation, 1 out of the 31 genes found as having a ribosome biogenesis 
function was also described as a regulator of alternative splicing59, while 17 other genes 
were described in a study as also related to neurogenesis60. SMN down-regulation, while 
commonly associated to neurogenesis-related processes, such as brain development61 and 
neuronal migration/differentiation62, has recently been found to have a function within the 
translation process63. Results were consistent with this study, as we observed an enrichment 
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of pathways related to protein synthesis and ribosome biogenesis.  
 Next, we investigated if the decrease of SMN expression had an impact on the 
splicing events occurring in the CNS. For this purpose we used DEXSeq, a software that 
tests for differential exon usage between two conditions. The analysis found 8304 exons as 
differentially expressed, corresponding to changes in the isoform expression of 3926 genes, 
1127 (28,7%) of which were also listed as DE genes. We also performed a GSEA for the list 
of X7/C24 genes with differential exon usage. This analysis showed (see Annex III – D. 
melanogaster) an emphasis on terms related to RNA splicing, neurogenesis, axon guidance, 
post transcriptional gene silencing and assembly of the spliceosomal complex. Focusing on 
the 33 genes associated to regulation of alternative mRNA splicing, via spliceosome, we 
found these genes were mostly related to the assembly of snRNP’s (mainly U2 and U12). 
Considering that SMN down-regulation has been previously shown to perturb the splicing of 
U12 intron-containing genes in vertebrates and Drosophila64, we investigated if our results 
were consistent with these findings. However, we could not confirm if the specific U12 introns 
described in this study were being affected, only the genes which contain these introns. Out 
of the 24 genes listed with U12 introns, 9 of them were found as having DE exons in our 
analysis, totalling 23 DE exons (Figure 20). 4 of the genes with predicted U12 intron targets 
were also found on the X7/C24 gene DEA - Tsp97E, Nhe3, CG16941 and CG17912. From 
these, only CG16941 has been shown to affect the regulation of alternative mRNA splicing59. 
These results, while not showing if the specific U12 introns are being affected, show that 
changes in SMN expression affect genes modified by U12.  
 
Figure 20 – Number of DE exons found on each gene predicted to be modified by the U12 snRNP. 
 Finally, in addition to the pipeline described in the methods, we also used the Tuxedo 
pipeline65 to map and quantify gene and isoform expression, as it is one of the most 
widespread analysis pipelines in bioinformatics and it provides the feature of detecting novel 
splicing isoforms, something that is not implemented in DEXSeq. This pipeline uses TopHat15 
for mapping reads, Cufflinks66 for transcript assembly, and Cuffdiff 65 for gene and isoform 
DEA. Results show that Cufflinks is not optimized for novel isoform discovery in Drosophila, 
resulting in a systematic prediction of gene fusion transcripts (Figure 21). This is probably 
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due to the difference in genome architecture between mammals and fly, which greatly differ 
in intron size67. While it is possible to change the average intron size and intergenic distance 
in TopHat’s options, some intergenic distances in D. melanogaster are as long as its introns 
and are not differentiated by Cufflinks. For example, Smn’s distance to nxf2 is less than 1kb, 
leading to a systematic fusion of both genes into a single transcript. 
 
 
Figure 21 – Example of aberrant transcripts predicted by the Cufflinks algorithm resulting from an 
artificial fusion of sequencing reads from closely positioned genes. 
 
3.1.4 – Assessment of the effect of read trimming on nucleotide frequency bias and 
read coverage  
 We observed that the first 10 reads on all libraries across all conditions show a bias in 
the per base sequence content (Figure 22), which has been previously described as a result 
from the use of random hexamer primers4 in library preparation. A second data analysis was 
performed, with the first 10 nucleotides trimmed off in order to determine if it would reduce 
the bias, provide higher alignment quality and consequentially a more accurate gene and 
exon DEA when compared to the full length read analysis. 
 
Figure 22 – Nucleotide abundance across read positions.  
 Results showed that trimming reads reduced the library size after the initial filtering 
steps (homopolymers, poly-A, and read quality), but increased the number of uniquely 
mapped reads to the genome (Figure 23a). A decrease in introns was also observed, due to 
the fact that since HTseq requires only a partial overlap between the coordinates of read 
positioning and gene annotation in the reference genome, it is more than likely that the 
number of partial overlaps will be reduced. Results also showed that the increase in aligned 
reads does not help in stabilizing variance between replicates. A gain in reads corresponding 
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to protein coding feature was also observed, increasing coverage in medium and long genes 
(Figure 23b). This gain in protein coding feature genes also caused changes in the DE 
analysis, with a small number of unique genes being found on both trimmed and full read 
approach and an overall decrease in DE genes (Figure 23c and 23d). Even though trimming 
the first 10 nucleotides somewhat improves read mapping, we found diminishing results in 
the downstream analysis when performing the DEA. Because of this and time constraints, we 
decided not to pursue the complete Drosophila analysis with read trimming, though if the 
same base sequence bias were to be observed in another study, we would recommend 
using the trimmed approach from the start. 
 
   
Figure 23 – Aligned read gain by trimming the first 10 nucleotides of each read. a) Gain in aligned reads, 
library size and reads with a protein coding feature for each condition. b) Linear regression of the number of reads 
gained across gene length. c) Overlap between Trimmed and Full gene DEA for X7/C24. d) Gene overlap 
between Trimmed and Full gene DEA for C24 
 
3.1.5 – Comparative analysis of the transcriptome profiles of C24 and X7/C24 flies 
 Briefly, the creation of the C24 model had the objective of identifying neuronal specific 
changes caused by the down-regulation of SMN in the CNS. However, results showed this 
approach was hindered due to library preparation problems and also lead us to hypothesize 
a) 
b) 
 c)  d) 
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that the presence of glial cells in the CNS, which have a high SMN expression, diluted the 
effects of the shRNA construct since these cells do not express elav. To confirm Smn 
expression levels in these libraries, a RT-qPCR quantification from total RNA samples was 
performed which showed a non-significant down-regulation of SMN (Figure 24), in 
agreement with the quantification found in the RNA-Seq libraries. We then expressed the 
same shRNA construct in a model which presents a genomic deletion of Smn, halving its 
expression in all tissues. This approach, while not as precise in finding neuronal-specific 
changes, produced a wider list of results which are consistent with previous publications in 
terms of affected pathways. Also, the RT-qPCR quantification of Smn for these libraries 
showed a very significant down-regulation (Figure 24). 
 
Figure 24 – RT-qPCR of SMN expression levels. From Amaral et al.(2013)
41
 
 Comparing gene DEA results between these two models, we found that 61 of the 79 
(77%) DE genes found in the 3x3 C24 DEA overlapped with the X7/C24 DE gene list, and 
152 out of the 209 (73%) DE genes from the 2x2 DEA overlapped with the X7/C24 DE gene 
list. In total, 49 genes were found in common between all three DEAs (Figure 25a). A number 
of the X7/C24 DE genes were also found in two other publications on SMA based on 
Drosophila models using similar fly disease models, one using Smn null larvae sequenced 
with RNA-Seq (Garcia et al.68), and the other based on a microarray study of a loss of 
function allele for Smn (Smn73Ao - Lee et al69). We found an overlap of 12 genes (Figure 25b), 
including the hallmark gene Smn. The gene cer (or crammer) was also found in all three 
studies and is known to be involved in long term memory regulation70. Although no relation 
between it and neuro-muscular junctions has been reported, a link between cer and another 
neurodegenerative disease, Alzheimer disease, has been made71. The other genes – 
CG10638, CG2233, CG6910, CG7394, CG9577, Cht5, d, e, RhoGEF4, and Spn43Aa – did 
not show a direct relation with splicing, motor degeneration, or neurodegenerative diseases. 
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Figure 25 – Overlap between the differentially expressed genes found in C24 and X7/C24 libraries. a) 
Overlap of the genes found in the two DEAs performed for C24 and the DEA for X7/C24. b) Overlap of the genes 
found in two previous studies and the DEA for X7/C24 libraries. The study represented by the red circle is based 
on RNA-Seq data (Garcia et al.
68
)
 
while the other, represented by a blue circle, is based on microarrays data (Lee 
et al.
69
) 
 As previously discussed, we established the hypothesis that the glial cells could be 
interfering with the effects of the shRNA in the down-regulation of SMN’s expression levels, 
which was then reinforced by the observation that more than 70% of the significant DE genes 
found on each of the C24 DEAs were also found on the X7/C24 DEA (Figure 25a). This 
suggested a change in the gene expression pattern that is dependent of SMN’s expression, 
despite the gene itself not being found as significantly DE, though it was not possible to test 
this with the C24 data alone. However, with the data produced in the X7 libraries we were 
able to perform a two-proportion z-test and determine if the impact of glial cells was 
statistically significant. To test this, we retrieved all genes annotated in Flybase as expressed 
in “neuron”, “glia” and “ubiquitous” and overlapped with the the gene DEA results. As seen 
below (Table 3), we found that there is a significantly smaller proportion of ubiquitous genes 
significantly DE in the WT vs C24 list, while having a higher sensitivity for expression 
changes in neuronal specific genes. This helps to confirm the established hypothesis, 
showing that even though there is no significant change in the expression of SMN in the WT 
vs C24 analysis, we can attribute this to a signal dilution effect caused by cell types not 
affected by the shRNA, as the effects of a lower SMN expression level are still being 
observed.  
 
Table 4 - Differentially expressed genes in C24 or X7/C24 flies that are classified as having neuronal, glial 
or ubiquitous expression in Flybase. The (*) symbol represents statistically significant differences in the 
relative proportion of identified genes between the two sample types using the two-proportion z-test are 
highlighted with (p < 0,05). 
 
Neuronal 
(442 genes) 
Glial 
(74 genes) 
Ubiquitous 
(2649 genes) 
C24 
(209 DE genes) 
20 genes* 
(9,5%) 
1 gene 
(0,5%) 
39 genes* 
(18,5%) 
X7/C24 
(2846 DE genes) 
109 genes 
(3,8%) 
29 genes 
(1,0%) 
743 genes 
(26.1%) 
a) b) 
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3.2 – Transcriptome profiling of motor neurons derived from SMA patient iPSCs 
 To study the effects of SMN’s down-regulation on human motor neurons differentiated 
from iPSC cultures, we analysed three different phenotypes. This analysis had the aim of 
uncovering which genes, exons and related pathways are affected by this down-regulation, 
as well assessing if the previous studies, made with non-human models, showed a high 
degree of conservation regarding ortholog gene expression changes. Like the Drosophila 
analysis, it followed the pipeline described in methods, which includes data quality filtering of 
the generated datasets, alignment to a reference genome, differential expression analysis of 
genes and exons, and gene set enrichment analyses. Also, given the results obtained from 
trimming the first 10 nucleotides on D. melanogaster were successful in reducing bias and 
raising protein coding gene coverage we decided to pursue this approach in the human data 
analysis from the start.  
 The human RNA-seq dataset consisted of 9 libraries with three replicates for three 
different conditions: control motor neuron cultures derived from a normal subject (NS), motor 
neuron cultures from the same cells transduced with an RNAi lentiviral vector targeting 
SMN1 (shSMN2) and motor neuron cultures derived from a type I SMA patient (SMAiPS). 
While the NS and shSMN2 datasets are composed of biological replicates, two of the 
SMAiPS libraries are technical replicates (SMAiPS 2 and 3) derived from the same pool of 
extracted RNA. Since there were only two individuals used for the generation of the iPSC 
cultures (one for the normal subject and one for the patient), the shSMN2 condition was 
developed to address the inherent genetic background variation between individuals. 
 An average of 101 million raw reads per library were obtained (Appendix I – H. 
sapiens), 90% of which passed the initial quality filtering process. On average, 84,5% of the 
filtered reads were aligned to the human genome and 58% of them were counted as part of a 
protein coding gene. After filtering, 79% of the transcriptome was covered, with an average 
sequencing depth of 79X and an average of 19469 protein coding genes expressed, out of a 
total of 25775. The filtering, trimming and duplicate removal did not discard any of the 
replicates on either approach (Figure 26a) however, since SMAiPS 2 and 3 are technical 
replicates  the library with the lower correlation value to SMAiPS1 was removed from the 
downstream analysis (ρSMAiPS 2 = 0,987 vs ρSMAiPS 3 = 0,988 in the correlation test). The 
three conditions showed a distinct phenotype assignment, separating the libraries according 
to their origin (Figure 28b). 
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Figure 26 – Human data assessment. a) Hierarchical clustering between human, showing a separation between 
all three conditions. b) Correlation plot between human libraries based on gene expression values normalized by 
DESeq.  
 To assess which genes were having its expression levels altered by SMNs down-
regulation in the SMA patient and the shSMN2 model, we performed a gene DEA. Two 
comparisons were made: NS vs SMAiPS and NS vs shSMN2. In the NS vs SMAiPS DEA, 
we found 8209 genes as DE (adj-p < 0,05) including SMN1 (log2 fold change: -7,55) and 
SMN2 (log2 fold change: 1,12). Many of these genes displayed medium to low expression 
levels which suggests the DE analysis might be biased due to sampling error. Comparatively, 
we found a much lower number of DE genes in the NS vs shSMN2 DEA (208 DE genes) and 
it did not feature either SMN1 or SMN2 as DE.  
 As we did not find significant expression changes of SMN1 in the shSMN2 libraries, 
we decided to perform a DEA between the two libraries which were expected to have a 
down-regulation of SMN – shSMN2 and SMAiPS. Results showed 8101 DE genes, 6803 of 
which overlapped with the NS vs SMAiPS analysis (~84% - Figure 27), including a down-
regulation of SMN1 (log2 fold change: -7,21) and an up-regulation of SMN2 (log2 fold change: 
1,09) with practically the same fold changes as the one found in the NS vs SMAiPS DEA. 
Since the shSMN2 construct was developed to solve the problem regarding the genetic 
background between iPSC cultures, this points to a problem with this model, probably due to 
the shRNA interference being weak. This could be related to an immune response by the 
cells to the shRNA (previously documented in mammalian cells72), disabling any effects 
a) b) 
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caused by RNA interference. 
 
Figure 27 - Overlap between the genes found as DE in the H. sapiens sequencing batch. 
 To further understand the biological context of these gene expression changes, we 
assessed which pathways were being affected by these variations by performing a GSEA. 
We found 356 significantly enriched BP pathways with the DE gene list from the NS vs 
SMAiPS analysis, 6 from the NS vs shSMN2 and 323 from the shSMN2 vs SMAiPS (adj-p < 
0,05). In both NS vs SMAiPS and NS vs shSMN2 GSEAs, we observed a high number of 
genes associated with neuronal growth and activity, and axon guidance (Table 5 and 6), 
which are biological processes that have been described in the literature as negatively 
affected by the down regulation of SMN. 
 
Table 5 - Selected terms (lowest adj-p) from the GSEA (BP) for the gene list obtained in the NSxSMAiPS 
gene DEA. Terms with a term size higher than 500 were filtered out. Other relevant terms not shown here include 
central nervous system projection neuron axonogenesis, neuron maturation, neuron projection morphogenesis 
and central nervous system neuron development 
GO ID 
Gene 
Count 
Term 
Size 
Terms 
Ajusted p-
value 
GO:0051960 289 441 regulation of nervous system development 1,70E-15 
GO:0045664 176 258 regulation of neuron differentiation 6,53E-12 
GO:0007411 228 354 axon guidance 3,26E-11 
GO:0007155 223 352 cell adhesion 6,60E-11 
GO:0007268 246 392 synaptic transmission 8,19E-11 
GO:0007610 264 429 behavior 4,57E-10 
GO:0030198 137 199 extracellular matrix organization 7,92E-10 
GO:0001568 287 477 blood vessel development 2,78E-09 
GO:0034329 77 101 cell junction assembly 5,22E-09 
GO:0001525 214 346 angiogenesis 1,71E-08 
GO:0051240 271 454 
positive regulation of multicellular organismal 
process 
1,71E-08 
GO:0060284 208 337 regulation of cell development 2,22E-08 
GO:0003001 199 320 generation of a signal involved in cell-cell signaling 3,03E-08 
GO:0022604 187 299 regulation of cell morphogenesis 4,42E-08 
GO:0042060 288 491 wound healing 4,90E-08 
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Table 6 - Selected terms (lowest adj-p) from the GSEA (BP) for the gene list obtained in the 
shSMN2xSMAiPS gene DEA. All terms with size higher than 500 were filtered. 
GO ID 
Gene 
Count 
Term 
Size 
Terms 
Ajusted p-
value 
GO:0051960 269 406 regulation of nervous system development 1,52E-15 
GO:0031344 180 256 regulation of cell projection organization 3,95E-14 
GO:0045664 215 318 regulation of neuron differentiation 6,07E-14 
GO:0022604 194 297 regulation of cell morphogenesis 1,39E-10 
GO:0007411 224 352 axon guidance 1,63E-10 
GO:0007155 265 439 cell adhesion 1,09E-09 
GO:0051240 274 451 positive regulation of multicellular organismal process 1,10E-09 
GO:0001568 282 467 blood vessel development 1,64E-09 
GO:0007517 201 321 muscle organ development 1,03E-08 
GO:0032970 132 199 regulation of actin filament-based process 4,50E-08 
GO:0001501 156 243 skeletal system development 4,83E-08 
GO:0090066 172 273 regulation of anatomical structure size 7,85E-08 
GO:0007268 226 378 synaptic transmission 1,25E-07 
GO:0010740 197 322 positive regulation of intracellular protein kinase cascade 1,30E-07 
GO:0050920 70 94 regulation of chemotaxis 1,39E-07 
 
Table 7 – Enriched terms from the GSEA (BP) for the gene list obtained in the NSxshSMN2 gene DEA. 
GO ID Gene Count Term Size Terms Ajusted p-value 
GO:0060337 6 59 type I interferon-mediated signaling pathway 0,000319376 
GO:0034340 6 60 response to type I interferon 0,000319376 
GO:0060282 2 2 positive regulation of oocyte development 0,000319376 
GO:0032836 3 10 glomerular basement membrane development 0,000337125 
GO:0016525 5 47 negative regulation of angiogenesis 0,000368576 
GO:0060384 3 14 innervation 0,000656759 
 
 The results for the NS vs shSMN2 evidenced an enrichment of pathways associated 
to interferon-based immune responses (Table 7). The two first terms were also found on the 
NS vs SMAiPS GSEA and in both of these analysis, all genes related to them were found to 
be down-regulated. 
 We also found a high number of genes related to viral infection such as the Hepatitis 
C disease pathway (KEGG term) when comparing the healthy individual’s iPSC cultures 
against the SMA patient (79 genes for NS vs SMAiPS, 76 for shSMN2 vs SMAiPS, out of a 
total of 116 known genes in this pathway. See Appendix III – H. sapiens). It is possible that 
the healthy individual fibroblasts contained a virus infection which carried over to the iPS cell 
cultures, which would explain the down-regulation of genes related to immune response in 
the SMAiPS libraries when compared to NS.  
 Finally, we assessed if the decrease of SMN1 expression causes significant changes 
in the cell genetic program in terms of differential exon usage. Results showed (adj-p <0,05) 
3052 DE exons in the NS vs SMAiPS analysis, corresponding to changes in 1496 genes, 
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4864 DE exons in shSMN2 vs SMAiPS (2254 genes), and finally 1991 exons in the NS vs 
shSMN2 analysis (1324 genes) (Figure 28).  
 Unlike in the GSEA for the DE gene list, the GSEA for NS vs SMAiPS DE exons 
showed 53 genes (see appendix III – H. sapiens) directly associated with RNA splicing 
including SNRNP200 (required in U4/U6 snRNP assembly), SNRPB2 (related to U2 snRNP) 
and SNRNP70 (encodes U1 snRNP). Pathways enriched in NS vs shSMN2 are again mostly 
related to virus-host interactions like the ones observed on DE gene GSEA.  
 
Figure 28 – Differentially expressed exons found on the human library DEXSeq analysis. 
 These observations, coupled with the fact that 90% of the genes in the shSMN2 vs 
SMAiPS gene DEA overlap with NS vs SMAiPS’s DEA, and the much closer correlation 
between the NS and shSMN2 libraries (~99%, see Figure 26b) versus the SMAiPS libraries 
(~85% and ~84%, respectively), lead us to the conclusion that the shSMN2 model was 
indeed not performing as expected, as there was no observable down-regulation of SMN and 
the gene DEA versus SMAiPS showed that there were no significant differences between it 
and the DEA between NS and SMAiPS. 
 Given the results presented here, we decided to compare the data to previous SMA 
studies to see if the same type of expression changes and pathways were found between 
studies. The caveat with this approach is that since most studies on SMA have been made 
on non-human models only known ortholog genes will be picked up by a comparative 
analysis, potentially discarding a long list of genes that have not previously been associated 
with SMA or are specific to a certain species. We used two mouse SMA studies based on 
microarrays for this comparison. The first study, by Zhang et al.73, is based on both brain and 
spinal cord tissues and uses shRNA to limit the expression levels of SMN in the mouse, 
similar to the ones presented on this thesis, with the exception that the interference in this 
case is ubiquitous. The second study, by Bäumer et al.36, is based on a spinal cord tissue 
assessment of a SMN null mouse model which expresses human SMN2 and SMNΔ7, known 
to extend the life-span of mouse SMN models (previously described in74). Results show a 
high overlap between DE human genes and DE mouse genes (~50% each), though a very 
small overlap was observed when overlapping the mice studies (~7% overlap) (Figure 29). 
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To confirm if these overlaps were statistically significant, we did a hypergeometric test using 
the total number of ortholog genes between mouse and human as the universe. Results 
showed the overlap made with Zhang et al. is statistically significant (p-value=0.032), while 
the overlap with Bäumer et al. is not (p-value=0.351). 
 We performed two GSEA analyses for the set of overlapping genes between our and 
these models. The GSEA for the Zhang et al. overlap found 50 significantly enriched 
biological process terms (see appendix III – Human-Mouse orthologs). The results are 
consistent with reported changes associated to the down-regulation of SMN expression, 
including neurogenesis, axon guidance, and neuron differentiation. No terms related to 
splicing were detected in the GSEA. Additionally, pathways such as viral infection, which had 
been attributed in humans to the biological variation between individuals, were not found.  
 On the other hand, the GSEA for the Baumer et al. overlap showed 19 enriched terms 
(see appendix III – Human-Mouse orthologs), which are not known to be reported as 
associated with SMA or SMN down-regulation. Our results suggest this model may not be 
appropriate to model SMA, as the enriched biological process terms found in the GSEA do 
not mirror the known SMA phenotype. We hypothesize this could be related to the fact that 
while SMNΔ7 is unstable in humans and is rapidly degraded, its effects on mice cause 
changes in gene expression unrelated to the SMA pathology.  
  
 
 
Figure 29 – Overlap between DE genes in the NSxSMAiPS DEA and two SMA studies on a M. musculus 
model. 
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3.3 – Integrated analysis of human and fly SMA models 
 To understand how conserved were the gene expression changes found in 
Drosophila in comparison to humans, we overlapped the X7/C24 DE gene list with the list of 
all known human-Drosophila orthologs. The same was made for the NS vs SMAiPS DE gene 
list. The two overlaps were then compared. We found 1419 gene hits in common between 
the human and Drosophila gene DEAs. A gene hit means that one gene may be an ortholog 
to more than one human/Drosophila gene (Figure 30a). To assess if the overlap was 
statistically significant, we performed a hypergeometric test.  Results show that this overlap 
is significant (p-value: 2.59e-14). Plotting the fold changes of these genes between species, 
we obtained a list of 740 genes (green) with the same type of expression change (i.e.: both 
up-regulated or down-regulated - Figure 30b). 
 
 
Figure 30 – H. sapiens and D. melanogaster differentially expressed genes which are also orthologs. a) 
Venn diagram representing the gene hits found in common between the DE gene lists for H. sapiens and D. 
melanogaster which are also ortholog genes between these species. b) Comparison between the fold changes of 
the ortholog genes found to be differentially expressed in both H. sapiens and D. melanogaster. The circles in 
green represent genes whose fold change is the same in both species (both positive /both negative). 
 For the list of 740 genes in common we performed two GSEAs, one for the 
Drosophila gene list and one for the human gene list, in order to assess if the ortholog genes 
were involved in similar pathways. The Drosophila GSEA found a set of 156 enriched 
biological process terms (adj-p < 0,05),  with an emphasis on neuron related processes and 
transportation, 68 of which are consistent with the ones found on the GSEA for the X7/C24 
DE genes. The human GSEA found a set of 51 enriched biological process terms (adj-p < 
0,05) with an emphasis on neuron related processes, RNA processing, ribosome biogenesis 
and protein assembly (see appendix III – Drosophila-human orthologs).  
 As mentioned in the Drosophila model GSEA analysis, the biological pathways 
related to ribosome biogenesis and protein assembly are in agreement with a recent find of a 
new SMN function related to translation63. Sanchez et al. found that in in vitro cultured 
human cells SMN associates with polyribosomes and is able to repress the translation of 
mRNAs. Mutations in SMN thus result in the upregulation of these mRNAs in SMA patients. 
a) b) 
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By showing an enrichment of genes involved in these processes, our results corroborate the 
suggestion that these specific pathways are affected by mutations in the SMN protein. 
Furthermore, these results suggest the comparison method is able identify genes and 
pathway changes which are central in the SMA pathology, filtering genetic variation related 
noise in the data. Despite the limitations discussed previously for both datasets, the results 
presented here give evidence for a conserved response to the down-regulation of SMN 
between species, with a significant overlap between the affected genes and pathways, 
suggesting the Drosophila model is indeed a good approach to model and study SMA 
disease. 
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4 – Final Remarks 
 The objectives in this thesis were to investigate how the decrease of SMN expression 
affects the genetic program of motor neurons via an RNA-seq approach. To do this, we 
studied the transcriptome of two disease models using RNA-Seq: a D. melanogaster RNAi 
model, and a human iPSC model of an SMA patient, both of them with decreased levels of 
SMN expression. We also aimed to assess the similarity between Drosophila and human 
models in order to understand the usability of D. melanogaster models in studying SMA. 
 Regarding the Drosophila model, results presented here are the first map of the 
transcriptome of the CNS of a Drosophila elavGAl4 transgenic strain, which contains a 
neuronal specific expression of a shRNA construct that targets the expression of Smn.  
Overall, across all three sequencing batches, we found that the achieved alignment coverage 
was consistent with other sequencing datasets on D. melanogaster, comparable to a mRNA-
seq Drosophila brain study by Hughes et al.75 and two whole-body transcriptome studies by 
Daines et al. and Gan et al., respectively76,77. Similarly to Hughes et al., only 70% of the 
reads generated in this dataset map to protein coding genes, 20% less than the 
modENCODE study for whole-body sequencing, suggesting that the D. melanogaster’s CNS 
transcriptome could potentially be enriched with intergenic transcripts, as reported in 
primates78. One of the biggest challenges found on this model was the amount of non-
neuronal tissue found on all datasets, due to the larvae brain extraction process needed to 
produce the libraries. Since RNA-Seq requires a large amount of RNA input, each library was 
comprised of an average of 200 larvae brains, each of them with varying levels of 
contamination from non-neuronal tissues. As mentioned above, we successfully developed a 
method to determine tissue specific expression and the effects of tissue contamination on 
library viability. This method and other solutions discussed here resulted in a publication 
while this thesis was being written41, focusing exclusively on the D. melanogaster shRNA 
model. Also, as shown in the results, RNA-Seq, while a viable and flexible technique, has 
various limitations related to library preparation and sequencing. A great part of the 
challenges found on these libraries was derived from library preparation, especially PCR 
amplification, which consequently forced discarding an average of 50% of the dataset. Finally, 
our results suggest that RNA-seq, for a proper comparison between different conditions, 
requires libraries that are prepared and sequenced in parallel, therefore mitigating the library 
preparation and sequencing batch effects. 
 Likewise, we found several challenges with the human model analysis. The approach 
used to take into account the biological variation existent between two individuals was to 
create a model based on the healthy individual where the SMN expression was decreased 
due to the targeting of an SMN specific shRNA. Results showed however, that this approach 
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did not work, leaving us with two libraries displaying a high gene expression variance, mostly 
due to the inherent sampling error of the technique that mainly affects medium to low 
expressed genes. Indeed, we found almost a third of the human annotated genes as 
differentially expressed when comparing them (NS vs SMAiPS). Still, we managed to 
determine which genes were potentially related to a response to SMN’s down-regulation by 
comparing those results to previous mouse-based SMA studies. 
 Despite having problems in both Drosophila and human models, it was possible to 
compare the gene expression between them, revealing several genes and pathways related 
to the decrease of expression conserved between species, indicating that the D. 
melanogaster is an apt model for studying SMA. 
 The analysis presented here sets up a starting point for a future, more accurate 
transcriptome study in both models using RNA-Seq. Regarding the D. melanogaster model, 
improving the sequencing libraries quality is key, which involves reducing the number of PCR 
cycles during library preparation (thus resulting in fewer duplicates). Also, for an unbiased 
analysis of the Drosophila data, a new dataset containing new libraries for WT and X7/C24 
will be required, which will also allow for a DEA that can take into account a possible 
sequencing batch effect when compared to the previous sequencing batches. Future shRNA 
based D. melanogaster models will also need to address the fact that since the CNS is a 
complex tissue, the presence of glial cells can undermine the process of detecting subtle 
variations in gene expression in the CNS, especially if the shRNA expression is mediated by 
elav, which is not expressed in these cells. Ideally, the best model would be based on 
completely isolating the neurons from the rest of the CNS. However this is an extremely 
technically complex procedure for it to be used in Drosophila. As for the H. sapiens iPSC 
model, sequencing batches need to be improved by increasing the number of biological 
replicates combined with the increase of sequencing depth, specifically by creating iPSC 
cultures from several different individuals, rather than using only one for each condition, 
therefore mitigating the false discovery rate by reducing the genetic background and 
increasing sequencing sampling. 
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6 – Appendixes 
I – Alignment tables  
 
a)  D. melanogaster - Quantification of cDNA input, read quality filtering, mapping and protein coding annotation 
statistics of paired-end mRNA-seq libraries. 
 
cDNA used 
(ng) 
Raw Reads 
(millions) 
Uniquely 
aligned 
(millions) 
Uniquely aligned 
w/out duplicates 
(millions) 
Reads mapped to 
protein coding 
genes (millions) 
Number of 
expressed 
genes 
Normalized 
average 
read 
depth/gene 
First Sequencing Batch 
C24 1 2 95,62 78,47 21,68 (27,63%) 15,77 (72,73%) 10725 2461 
C24 2 6 112,11 87,95 53,45 (60,77%) 40,19 (75%) 11632 1353 
C24 3 4 97,43 80,90 31,26 (38,64%) 21,85 (70%) 10975 1449 
C24 4 3 111,77 85,32 51,07 (59,86%) 38,14 (75%) 12092 1322 
WT 1 5 104,46 85,35 38,04 (44,57%) 29,42 (77%) 11985 1188 
WT 2 2 106,03 87,69 23,52 (26,82%) 18,04 (76,7%) 10758 2186 
WT 3 4 112,71 87,02 45,95 (52,80%) 33,83 (74%) 11712 1273 
Second Sequencing Batch 
C24 5 13 86,25 65,83 48,39 (73,51%) 36,87 (76%) 11667 1506 
C24 6 7 100,34 77,9 53,20 (68,29%) 40,47 (76%) 11669 1311 
C24 7 12 98,35 77,40 53,17 (68,70%) 39,95 (75%) 11970 1471 
WT 4 11 126,82 95,5 70,45 (73,77%) 53,95 (77%) 11964 1442 
WT 5 10 84,38 66,12 47,21 (71,40%) 36,52 (77%) 11691 1426 
WT 6 12 113,96 87,50 67,27 (76,88%) 53,40 (79%) 11984 1457 
Third Sequencing Batch 
X7/C24 A 4 75,45 60,86 44,83 (73,66%) 33,60 (75%) 11665 1523 
X7/C24 B 7 95,06 73,81 58,75 (79,60%) 43,81 (75%) 11935 1473 
X7/C24 C 6 116,27 96,55 73,98 (76,62%) 56,70 (77%) 12096 1430 
X7/C24 D 3 116,12 88,27 44,06 (49,92%) 33,03 (75%) 11386 1346 
 
b)  H. sapiens - Quantification of cDNA input, read quality filtering, mapping and protein coding annotation 
statistics of paired-end mRNA-seq libraries. 
 
Raw Reads 
(millions) 
Uniquely 
aligned 
(millions) 
Uniquely aligned 
w/out duplicates 
(millions) 
Reads mapped to protein 
coding genes (millions) 
Number of 
expressed 
genes 
Normalized 
average read 
depth/gene 
NS 1 116,42 101,05 71,26 (70,53%) 41,71 (59%) 19504 1338 
NS 2 113,14 97,47 69,12 (70,93%) 41,03 (59%) 19316 1388 
NS 3 112,2 97,54 69,82 (71,58%) 40,51 (58%) 19500 1340 
shSMN2 1 80,86 70,11 50,5 (72,06%) 29,13 (58%) 19246 1311 
shSMN2 2 99,46 86,48 63,16 (73,04%) 36,35 (58%) 19404 1353 
shSMN2 3 88,6 77,27 55,06 (71,28%) 31,63 (57%) 19353 1344 
SMAiPS 1 99,42 79,42 63,86 (80,41%) 36,45 (57%) 19669 1177 
SMAiPS 2 87,76 70,29 54,94 (78,17%) 31,09 (57%) 19481 1192 
SMAiPS 3 110,46 88,92 69,22 (88,92%) 40,91 (59%) 19749 1159 
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II – Tissue specific genes expression assessment for the WT_5 and C24_6 
samples 
 
 
a) Neuronal exclusive genes with an expected high expression level 
 
 
b) Digestive system genes with a significant expression (>400 reads) in WT_5 and C24_6 
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c) Imaginal Discs genes with a significant expression (>400 reads) in WT_5 and C24_6 
 
 
d) Carcass genes with a significant expression (>400 reads) in WT_5 and C24_6 
 
 
e) Salivary gland genes with a significant expression (>400 reads) in WT_5 and C24_6 
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f) Fat body with a significant expression (>400 reads) in WT_5 and C24_6 
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III – GSEA results 
D. melanogaster 
 a) Selected terms from the GSEA (BP) for the list of genes obtained in the WTxX7/C24 gene DEA.  
GO ID Gene Count Term Size Terms (down-regulated genes) Ajusted p-value 
GO:0006396 89 379 RNA processing 6,10E-13 
GO:0022008 205 1257 neurogenesis 3,96E-11 
GO:0042254 16 26 ribosome biogenesis 1,93E-09 
GO:0006270 11 13 DNA replication initiation 6,06E-09 
GO:0006418 19 40 tRNA aminoacylation for protein translation 1,65E-08 
GO:0006399 27 76 tRNA metabolic process 2,25E-08 
GO:0006364 15 29 rRNA processing 1,27E-07 
GO:0006261 17 39 DNA-dependent DNA replication 3,05E-07 
GO:0016071 60 300 mRNA metabolic process 1,50E-06 
GO:0006281 24 80 DNA repair 2,77E-06 
GO:0034660 17 50 ncRNA metabolic process 1,23E-05 
GO:0000077 21 77 DNA damage checkpoint 5,78E-05 
GO:0000398 44 226 mRNA splicing, via spliceosome 6,67E-05 
GO:0000375 44 227 RNA splicing, via transesterification reactions 6,85E-05 
GO:0006260 12 32 DNA replication 7,19E-05 
GO:0071897 11 28 DNA biosynthetic process 9,73E-05 
GO:0034504 19 70 protein localization to nucleus 0,000106218 
GO:0006298 5 8 mismatch repair 0,000606523 
GO:0006398 5 8 histone mRNA 3'-end processing 0,000606523 
  
GO ID Gene Count Term Size Terms (up-regulated genes) Ajusted p-value 
GO:0002165 150 576 instar larval or pupal development 2,62E-18 
GO:0048569 122 451 post-embryonic organ development 2,88E-16 
GO:0048699 157 730 generation of neurons 1,61E-11 
GO:0048592 75 264 eye morphogenesis 4,46E-11 
GO:0040011 103 485 locomotion 1,16E-07 
GO:0031175 99 484 neuron projection development 9,93E-07 
GO:0007399 236 1438 nervous system development 2,92E-06 
GO:0048645 21 54 organ formation 3,49E-06 
GO:0007409 61 280 axonogenesis 1,85E-05 
GO:0000122 32 119 
negative regulation of transcription from RNA polymerase II 
promoter 
3,39E-05 
GO:0007420 30 110 brain development 4,40E-05 
GO:0007479 9 16 leg disc proximal/distal pattern formation 7,64E-05 
GO:0048666 29 116 neuron development 0,000130668 
GO:0007517 52 253 muscle organ development 0,00021038 
GO:0045944 37 168 
positive regulation of transcription from RNA polymerase II 
promoter 
0,000380385 
GO:0006376 5 7 mRNA splice site selection 0,000573674 
GO:0051254 47 237 positive regulation of RNA metabolic process 0,000681019 
GO:0051253 47 238 negative regulation of RNA metabolic process 0,000714817 
GO:0006355 123 760 regulation of transcription, DNA-dependent 0,000742307 
GO:0008045 14 45 motor neuron axon guidance 0,000758698 
 
 48 
 
b)  Selected terms from the GSEA (BP) for the list of genes obtained in the WT vs X7/C24 exon DEA 
GO ID Gene Count Term Size Terms 
Ajusted p-
value 
GO:0007411 106 187 axon guidance 1,90E-11 
GO:0045664 37 56 regulation of neuron differentiation 5,95E-07 
GO:0000375 110 227 RNA splicing, via transesterification reactions 6,20E-07 
GO:0050768 23 29 negative regulation of neurogenesis 7,76E-07 
GO:0022008 208 527 neurogenesis 6,00E-06 
GO:0000398 99 212 mRNA splicing, via spliceosome 1,27E-05 
GO:0016441 26 39 posttranscriptional gene silencing 2,25E-05 
GO:0031647 23 34 regulation of protein stability 4,62E-05 
GO:0043484 38 67 regulation of RNA splicing 5,40E-05 
GO:0000381 33 56 regulation of alternative mRNA splicing, via spliceosome 6,08E-05 
GO:0008582 22 33 regulation of synaptic growth at neuromuscular junction 8,47E-05 
GO:0051961 18 25 negative regulation of nervous system development 9,08E-05 
GO:0048675 19 27 axon extension 9,11E-05 
GO:0045886 17 24 negative regulation of synaptic growth at neuromuscular junction 0,000171003 
GO:0007399 22 38 nervous system development 0,000284095 
GO:0048699 33 63 generation of neurons 0,000289724 
GO:0000245 11 14 spliceosomal complex assembly 0,000542576 
GO:0007416 15 22 synapse assembly 0,00056001 
GO:0016246 12 16 RNA interference 0,000587362 
GO:0030422 8 9 production of siRNA involved in RNA interference 0,000765454 
 
H. sapiens 
a) Selected terms from the GSEA (BP) for the list of genes obtained in the NS vs SMAiPS exon DEA 
GO ID Gene Count Term Size Terms Ajusted p-value 
GO:0048667 87 558 cell morphogenesis involved in neuron differentiation 7,09E-06 
GO:0048812 88 565 neuron projection morphogenesis 7,09E-06 
GO:0016032 102 679 viral reproduction 7,09E-06 
GO:0019048 57 359 virus-host interaction 0,00012509 
GO:0044403 65 427 symbiosis, encompassing mutualism through parasitism 0,000135261 
GO:0007411 56 354 axon guidance 0,000143802 
GO:0030182 125 965 neuron differentiation 0,000173414 
GO:0031333 17 68 negative regulation of protein complex assembly 0,000254384 
GO:0031123 21 95 RNA 3'-end processing 0,000279915 
GO:0006378 9 24 mRNA polyadenylation 0,000335514 
GO:0016199 4 5 axon midline choice point recognition 0,000520432 
GO:0008380 49 319 RNA splicing 0,000520432 
GO:0022008 137 1115 neurogenesis 0,000534367 
GO:0048011 36 220 nerve growth factor receptor signaling pathway 0,000745069 
GO:0035385 3 3 Roundabout signaling pathway 0,000880441 
GO:0022604 45 299 regulation of cell morphogenesis 0,000969473 
GO:0010608 51 351 posttranscriptional regulation of gene expression 0,000983307 
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b) Selected terms from the GSEA (BP) for the list of genes obtained in the shSMN2 vs SMAiPS exon DEA 
GO ID Gene Count Term Size Terms Ajusted p-value 
GO:0048667 87 558 cell morphogenesis involved in neuron differentiation 7,09E-06 
GO:0048812 88 565 neuron projection morphogenesis 7,09E-06 
GO:0016032 102 679 viral reproduction 7,09E-06 
GO:0019048 57 359 virus-host interaction 0,00012509 
GO:0007411 56 354 axon guidance 0,000143802 
GO:0030182 125 965 neuron differentiation 0,000173414 
GO:0031123 21 95 RNA 3'-end processing 0,000279915 
GO:0042692 46 285 muscle cell differentiation 0,000298434 
GO:0006378 9 24 mRNA polyadenylation 0,000335514 
GO:0016199 4 5 axon midline choice point recognition 0,000520432 
GO:0008380 49 319 RNA splicing 0,000520432 
GO:0022008 137 1115 neurogenesis 0,000534367 
GO:0048011 36 220 nerve growth factor receptor signaling pathway 0,000745069 
GO:0035385 3 3 Roundabout signaling pathway 0,000880441 
GO:0070271 97 762 protein complex biogenesis 0,000971005 
 
c) GSEA (BP) for the list of genes obtained in the NS vs shsMN2 exon DEA 
GO ID Gene Count Term Size Terms 
Ajusted p-
value 
GO:0051704 148 1199 multi-organism process 1,69E-05 
GO:0016032 91 669 viral reproduction 3,92E-05 
GO:0044703 92 690 multi-organism reproductive process 5,93E-05 
GO:0044403 60 412 symbiosis, encompassing mutualism through parasitism 0,000100112 
GO:1901575 194 1739 organic substance catabolic process 0,000100112 
GO:0019048 52 352 virus-host interaction 0,000159311 
GO:0006397 55 390 mRNA processing 0,000250884 
GO:0031175 86 682 neuron projection development 0,000250884 
GO:0048002 28 173 antigen processing and presentation of peptide antigen 0,000743366 
GO:0031123 18 95 RNA 3'-end processing 0,00096844 
GO:0019884 26 160 antigen processing and presentation of exogenous antigen 0,00096844 
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d)  GSEA (KEGG) for the list of genes obtained in the NS vs SMAiPS gene DEA 
KEGGID Gene Count Term Size Terms Ajusted p-value 
4510 132 197 Focal adhesion 1,90E-08 
5200 199 320 Pathways in cancer 1,90E-08 
4810 130 204 Regulation of actin cytoskeleton 1,35E-06 
4512 60 83 ECM-receptor interaction 4,84E-06 
4514 83 123 Cell adhesion molecules (CAMs) 4,84E-06 
4360 86 129 Axon guidance 5,68E-06 
4144 118 193 Endocytosis 4,35E-05 
4670 72 110 Leukocyte transendothelial migration 7,95E-05 
5414 59 87 Dilated cardiomyopathy 7,95E-05 
5160 76 118 Hepatitis C 9,05E-05 
5100 48 69 Bacterial invasion of epithelial cells 0,000132172 
4380 70 109 Osteoclast differentiation 0,00017424 
4020 101 167 Calcium signaling pathway 0,000180268 
4530 79 126 Tight junction 0,000180268 
5412 49 72 Arrhythmogenic right ventricular cardiomyopathy (ARVC) 0,000184997 
5140 45 65 Leishmaniasis 0,000184997 
4060 116 197 Cytokine-cytokine receptor interaction 0,000203461 
 
e) GSEA (KEGG) for the list of genes obtained in the shSMN2 vs SMAiPS gene DEA  
KEGGID Gene Count Term Size Terms Ajusted p-value 
4510 128 193 Focal adhesion 6,14E-08 
4360 90 128 Axon guidance 9,60E-08 
4512 63 83 ECM-receptor interaction 9,63E-08 
4514 83 120 Cell adhesion molecules (CAMs) 5,83E-07 
5414 61 83 Dilated cardiomyopathy 7,47E-07 
4810 126 199 Regulation of actin cytoskeleton 8,09E-07 
5200 186 315 Pathways in cancer 1,72E-06 
5410 53 76 Hypertrophic cardiomyopathy (HCM) 3,82E-05 
5412 50 71 Arrhythmogenic right ventricular cardiomyopathy (ARVC) 3,84E-05 
4530 79 124 Tight junction 6,05E-05 
5140 44 62 Leishmaniasis 7,31E-05 
4670 68 107 Leukocyte transendothelial migration 0,000195687 
5160 73 118 Hepatitis C 0,000356237 
5131 41 60 Shigellosis 0,000388376 
4971 46 69 Gastric acid secretion 0,000388376 
5146 58 91 Amoebiasis 0,000401767 
4020 99 170 Calcium signaling pathway 0,000603004 
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Human-Mouse orthologs 
a) Selected terms (lowest adj-p) from the GSEA (BP) for the list of human genes obtained in the overlap between 
NS vs SMAiPS and Zhang et al. 
GO ID Gene Count Term Size Terms Ajusted p-value 
GO:0030199 10 37 collagen fibril organization 1,56E-10 
GO:0043062 14 200 extracellular structure organization 5,54E-07 
GO:0048667 20 558 cell morphogenesis involved in neuron differentiation 2,13E-05 
GO:0048812 20 565 neuron projection morphogenesis 2,13E-05 
GO:0022610 26 905 biological adhesion 2,13E-05 
GO:0007411 15 354 axon guidance 3,71E-05 
GO:0048646 35 1546 anatomical structure formation involved in morphogenesis 4,86E-05 
GO:0030030 25 921 cell projection organization 5,83E-05 
GO:0030155 12 259 regulation of cell adhesion 9,72E-05 
GO:0030182 25 965 neuron differentiation 0,0001034 
GO:0071230 5 35 cellular response to amino acid stimulus 0,000113901 
GO:0001101 7 85 response to acid 0,000113901 
GO:0032990 20 683 cell part morphogenesis 0,000113901 
GO:0042330 17 559 taxis 0,000242821 
GO:0009611 24 983 response to wounding 0,000242821 
GO:0022008 26 1115 neurogenesis 0,000242821 
GO:0071840 65 4129 cellular component organization or biogenesis 0,000242821 
GO:0043206 3 10 extracellular fibril organization 0,00031966 
GO:0007160 8 143 cell-matrix adhesion 0,00031966 
GO:0050896 85 6008 response to stimulus 0,00031966 
 
b) Selected terms (lowest adj-p) from the GSEA (BP) for the list of human genes obtained in the overlap between 
NS vs SMAiPS and Bäumer et al. 
GO ID Gene Count Term Size Terms Ajusted p-value 
GO:0009628 21 727 response to abiotic stimulus 0,000290805 
GO:0097411 2 2 hypoxia-inducible factor-1alpha signaling pathway 0,000497182 
GO:0006817 3 10 phosphate ion transport 0,000497182 
GO:0046479 3 10 glycosphingolipid catabolic process 0,000497182 
GO:0044255 20 780 cellular lipid metabolic process 0,000497182 
GO:0019216 9 197 regulation of lipid metabolic process 0,000564819 
GO:0007173 8 158 epidermal growth factor receptor signaling pathway 0,000564819 
GO:2000377 5 56 regulation of reactive oxygen species metabolic process 0,000564819 
GO:0009409 4 31 response to cold 0,000564819 
GO:0048511 8 169 rhythmic process 0,000608745 
GO:0042136 3 14 neurotransmitter biosynthetic process 0,000608745 
GO:0045017 9 219 glycerolipid biosynthetic process 0,00063572 
GO:0048011 9 220 nerve growth factor receptor signaling pathway 0,00063572 
GO:0009725 16 610 response to hormone stimulus 0,000684042 
GO:0008543 7 138 fibroblast growth factor receptor signaling pathway 0,000684042 
GO:0046514 3 17 ceramide catabolic process 0,00076443 
GO:0019318 9 236 hexose metabolic process 0,000806154 
GO:1901652 11 341 response to peptide 0,000806602 
GO:0007163 6 111 establishment or maintenance of cell polarity 0,000972661 
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Human-Drosophila orthologs 
a) Selected terms (lowest adj-p) from the GSEA (BP) for the human gene list obtained from the overlap of 
NSxSMAiPS DE genes with the X7/C24 DE genes. 
GO ID Gene Count Term Size Terms Ajusted p-value 
GO:0048699 127 1048 generation of neurons 3,68E-05 
GO:0048489 17 66 synaptic vesicle transport 0,000158548 
GO:0030204 15 55 chondroitin sulfate metabolic process 0,000198665 
GO:0045595 115 983 regulation of cell differentiation 0,00021977 
GO:0030155 40 259 regulation of cell adhesion 0,000286032 
GO:0005975 91 746 carbohydrate metabolic process 0,000286032 
GO:0051960 59 441 regulation of nervous system development 0,00043257 
GO:0048731 96 861 system development 0,000451936 
GO:0015031 134 1212 protein transport 0,000451936 
GO:0048646 165 1546 anatomical structure formation involved in morphogenesis 0,000451936 
GO:0071372 5 8 cellular response to follicle-stimulating hormone stimulus 0,000462707 
GO:0006096 14 58 glycolysis 0,000462707 
GO:0042593 22 117 glucose homeostasis 0,000462707 
GO:0030029 59 451 actin filament-based process 0,000462707 
GO:0006461 90 760 protein complex assembly 0,000462707 
GO:0016192 70 570 vesicle-mediated transport 0,00046332 
GO:0031109 12 47 microtubule polymerization or depolymerization 0,00057094 
GO:0007417 81 677 central nervous system development 0,00057094 
GO:0031175 82 689 neuron projection development 0,00057094 
GO:0006082 107 947 organic acid metabolic process 0,00057094 
GO:0019320 17 85 hexose catabolic process 0,00069096 
GO:0045766 17 85 positive regulation of angiogenesis 0,00069096 
GO:0042254 25 149 ribosome biogenesis 0,00069096 
GO:0045664 44 321 regulation of neuron differentiation 0,00069096 
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b) Selected terms (lowest adj-p) from the GSEA (BP) for the fly gene list obtained from the overlap of 
NSxSMAiPS DE genes with the X7/C24 DE genes. 
GO ID Gene Count Term Size Terms Ajusted p-value 
GO:0048569 78 451 post-embryonic organ development 4,47E-08 
GO:0048812 79 483 neuron projection morphogenesis 3,12E-07 
GO:0007269 29 112 neurotransmitter secretion 6,09E-07 
GO:0046903 39 179 secretion 6,09E-07 
GO:0040011 78 485 locomotion 6,09E-07 
GO:0007268 52 276 synaptic transmission 6,13E-07 
GO:0007389 52 281 pattern specification process 6,13E-07 
GO:0003001 30 121 generation of a signal involved in cell-cell signaling 8,50E-07 
GO:0016192 72 443 vesicle-mediated transport 9,76E-07 
GO:0035637 52 283 multicellular organismal signaling 1,19E-06 
GO:0042067 19 59 establishment of ommatidial planar polarity 2,15E-06 
GO:0001738 27 108 morphogenesis of a polarized epithelium 2,44E-06 
GO:0051674 47 251 localization of cell 2,44E-06 
GO:0001709 32 142 cell fate determination 2,60E-06 
GO:0016477 44 230 cell migration 2,66E-06 
GO:0048729 54 308 tissue morphogenesis 2,66E-06 
GO:0007164 25 97 establishment of tissue polarity 3,03E-06 
GO:0048737 61 372 imaginal disc-derived appendage development 4,73E-06 
GO:0006928 62 381 cellular component movement 4,86E-06 
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IV – Protocols 
 
Protocol 1 - Data Filtering 
1) The protocol starts out with 3 files for each read of each condition’s replicates: 
condition_replicate_read_ID.fastq, condition_replicate_read_SEQ.fastq and condition_replicate _read_QS.fastq 
which contain, respectively, the ID from the read, the read's sequence and the quality score of each nucleotide. 
These are joined into one table with a simple bash command: 
$ paste <ID.fastq> <SEQ.fastq> <QS.fastq>  >  TABLE.fastq 
 
2) These tables are then filtered with a perl script created for this purpose, which removes the homopolymers 
equal or longer than 50% of the read’s total size, non called bases and reads with a QS lower than 30: 
$ perl filter_RNAseq_Harvard2.pl <input_TABLE.fastq> <output_TABLE_filtered.fastq> 
 
3) From these filtered tables, we now need to know which reads still have their pair, which can be done with a 
script also created for this purpose. First we need to extract the ID’s from each read and join them in pairs, for 
each replicate. 
$ cut -f <Read_1_TABLE_filtered.fastq>  > IDlist_Read1 
$ cut -f <Read_2_TABLE_filtered.fastq>  > IDlist_Read2 
$ cat <IDlist_Read1 IDlist_Read2>  >> IDlist_both_reads 
 
4) Finally, a Perl in-house script  identifies and removes reads which don’t have both pairs featured after filtering: 
$ perl prepare_fastq_RNAseq_paired_ends_line.pl <IDlist_both_reads> <Read1_TABLE_filtered.fastq> 
<Read1_filtered_TABLE_paired.fastq> 1:N:0: 
$ perl prepare_fastq_RNAseq_paired_ends_line.pl <IDlist_both_reads> <Read2_TABLE_filtered.fastq> 
<Read2_filtered_TABLE_paired.fastq> 2:N:0: 
 
 
Protocol 2 - BWA alignment, gene count with HTseq and DEA/visualization with 
DESeq/DEXSeq 
1)  Retrieve the reference genome in fasta format, in order to create the BWT indexes: 
$ bwa index [-a is/bwswt] <genome.fa> 
 
2) The aln command finds the suffix array coordinates of the input reads. Using read 1 as an example: 
$ bwa aln [-n edit distance] [-t nThreads] <index> <Read1_filtered_TABLE_paired.fastq> <out.sai> 
 
3) The sampe command converts SA coordinates to chromosomal coordinates, generating the alignments in SAM 
format, given paired-end reads.  
$ bwa sampe  [-n maxHitPaired] [-N maxHitDistance] <index> <Read1.sai> <Read2.sai> 
<Read1_filtered_TABLE_paired.fastq> <Read2_ filtered_TABLE_paired.fastq> > <paired.sam> 
 
4) Removal of PCR duplicates is made with samtools. Since the software which removes the duplicates needs to 
work with .bam files, first we need to convert the file from .sam to its binary form (.bam), sort it by chromosome, 
run the duplicate removal tool, sort it by read pairs and finally, convert it back to .sam  
$  samtools view [-bS .bam from .sam] [-o output] paired.bam paired.sam & 
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$  samtools sort paired.bam paired_sorted &  
 $  samtools rmdup paired_sorted.bam paired_no_duplicates.bam & 
 $  samtools sort [-n by read] paired_no_duplicates.bam paired_clean & 
 $  samtools view [-h bam to sam] [-o output] paired_clean.sam paired_clean.bam &  
 
5) HTSeq is then used to do the gene count, using one of two approaches: union and intersect_strict. Note that 
the default option for –m (mode) is union. 
$ htseq-count [-a skip QS < than n]  [-s strand specific? (yes/no)] [-m union/intersection-strict] 
<paired.sam> <genome.gff> > <output.table>  
 
6) DESeq/DEXSeq analysis. An R script for each package was created based on the bioconductor vignettes, 
which normalizes library sizes and analyses the differential gene/isoform expression between samples and allows 
for graphical visualization of the data. 
 
Protocol 3 – GAL4 quantification 
1) Retrieve the GAL4 sequence (Gene ID 855828; accession NC_001148.4) in fasta format and create a BWT 
index for alignment 
$ bwa index [-a is/bwswt] <genome.fa> 
2) Using the files created in Protocol 1, follow Protocol 2’s steps 1) through 4) using the newly created reference 
“genome” 
3) Count the aligned to GAL4 reads using the command line and write them to a text file 
$ awk '$3=="gi|330443753:c82356-79711" { print $0 }' GAL4search_EXAMPLE.sam > 
GAL4search_EXAMPLE_aligned & 
 
